BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S, Bacq Y, Leteurtre E, Paradis V, Michalak S, Wendum D, Chiche L, Fabre M, Mellottee L, Laurent C, Partensky C, Castaing D, Zafrani ES, Laurent-Puig P, Balabaud C, Bioulac-Sage P. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology. 2006;43:515-524. [PMID: 16496320 DOI: 10.1002/hep.21068] [Cited by in Crossref: 559] [Cited by in F6Publishing: 454] [Article Influence: 34.9] [Reference Citation Analysis]
Number Citing Articles
1 Molinari M, Kaltenmeier C, Samra P, Liu H, Wessel C, Lou Klem M, Dharmayan S, Emmanuel B, Al Harakeh H, Tohme S, Geller D, Tevar A, Hughes CB, Humar A, Bataller R, Behari J. Hepatic Resection for Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of 7226 Patients. Annals of Surgery Open 2021;2:e065. [DOI: 10.1097/as9.0000000000000065] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chandler CM, Labadie KP, Park JO, Truong CD. Hepatocellular carcinoma arising within a β-catenin mutated inflammatory hepatic adenoma. Human Pathology: Case Reports 2021;24:200501. [DOI: 10.1016/j.ehpc.2021.200501] [Reference Citation Analysis]
3 Vijay A, Elaffandi A, Khalaf H. Hepatocellular adenoma: An update. World J Hepatol 2015; 7(25): 2603-2609 [PMID: 26557953 DOI: 10.4254/wjh.v7.i25.2603] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
4 Klompenhouwer AJ, Ijzermans JNM. Malignant potential of hepatocellular adenoma. Liver Int 2017;37:966-7. [DOI: 10.1111/liv.13449] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
5 Koch LK, Yeh MM. Nonalcoholic fatty liver disease (NAFLD): Diagnosis, pitfalls, and staging. Ann Diagn Pathol 2018;37:83-90. [PMID: 30312882 DOI: 10.1016/j.anndiagpath.2018.09.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
6 Klompenhouwer AJ, Sprengers D, Willemssen FEJA, Gaspersz MP, Ijzermans JNM, De Man RA. Evidence of good prognosis of hepatocellular adenoma in post-menopausal women. Journal of Hepatology 2016;65:1163-70. [DOI: 10.1016/j.jhep.2016.07.047] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
7 Di Tommaso L, Roncalli M. Tissue Biomarkers in Hepatocellular Tumors: Which, When, and How. Front Med (Lausanne). 2017;4:10. [PMID: 28280721 DOI: 10.3389/fmed.2017.00010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
8 Vennarecci G, Santoro R, Antonini M, Ceribelli C, Laurenzi A, Moroni E, Burocchi M, Lepiane P, Ettorre GM. Liver transplantation for recurrent hepatic adenoma. World J Hepatol 2013; 5(3): 145-148 [PMID: 23556048 DOI: 10.4254/wjh.v5.i3.145] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
9 Rodrigues BT, Mei SLCY, Fox A, Lubel JS, Nicoll AJ. A systematic review on the complications and management of hepatic adenomas: a call for a new approach. Eur J Gastroenterol Hepatol 2020;32:923-30. [PMID: 32433418 DOI: 10.1097/MEG.0000000000001766] [Reference Citation Analysis]
10 Laumonier H, Bioulac-Sage P, Laurent C, Zucman-Rossi J, Balabaud C, Trillaud H. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology. 2008;48:808-818. [PMID: 18688875 DOI: 10.1002/hep.22417] [Cited by in Crossref: 223] [Cited by in F6Publishing: 172] [Article Influence: 15.9] [Reference Citation Analysis]
11 Rebouissou S, Couchy G, Libbrecht L, Balabaud C, Imbeaud S, Auffray C, Roskams T, Bioulac-Sage P, Zucman-Rossi J. The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules. J Hepatol 2008;49:61-71. [PMID: 18466996 DOI: 10.1016/j.jhep.2008.03.013] [Cited by in Crossref: 61] [Cited by in F6Publishing: 48] [Article Influence: 4.4] [Reference Citation Analysis]
12 Joseph NM, Blank A, Shain AH, Gill RM, Umetsu SE, Shafizadeh N, Torbenson MS, Kakar S. Hepatocellular Neoplasms with Loss of Liver Fatty Acid Binding Protein: Clinicopathologic Features and Molecular Profiling. Human Pathology 2022. [DOI: 10.1016/j.humpath.2022.01.007] [Reference Citation Analysis]
13 Bellamy COC, Maxwell RS, Prost S, Azodo IA, Powell JJ, Manning JR. The value of immunophenotyping hepatocellular adenomas: consecutive resections at one UK centre: Hepatocellular adenomas. Histopathology 2013;62:431-45. [DOI: 10.1111/his.12011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
14 Sakellariou S, Al-Hussaini H, Scalori A, Samyn M, Heaton N, Portmann B, Tobal K, Quaglia A. Hepatocellular adenoma in glycogen storage disorder type I: a clinicopathological and molecular study. Histopathology. 2012;60:E58-E65. [PMID: 22372484 DOI: 10.1111/j.1365-2559.2011.04153.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
15 Apte U, Thompson MD, Cui S, Liu B, Cieply B, Monga SP. Wnt/beta-catenin signaling mediates oval cell response in rodents. Hepatology. 2008;47:288-295. [PMID: 17929301 DOI: 10.1002/hep.21973] [Cited by in Crossref: 128] [Cited by in F6Publishing: 116] [Article Influence: 9.1] [Reference Citation Analysis]
16 Micchelli ST, Vivekanandan P, Boitnott JK, Pawlik TM, Choti MA, Torbenson M. Malignant transformation of hepatic adenomas. Mod Pathol. 2008;21:491-497. [PMID: 18246041 DOI: 10.1038/modpathol.2008.8] [Cited by in Crossref: 94] [Cited by in F6Publishing: 63] [Article Influence: 6.7] [Reference Citation Analysis]
17 Shafaee Z, Liu S, Fiel MI, Blue R. Giant pedunculated hepatocellular adenoma masquerading as a subdiaphragmatic mass: Diagnostic challenges of a rare tumor. Radiol Case Rep 2021;16:84-9. [PMID: 33193934 DOI: 10.1016/j.radcr.2020.10.047] [Reference Citation Analysis]
18 Cho SJ, Ferrell LD, Gill RM. Expression of liver fatty acid binding protein in hepatocellular carcinoma. Hum Pathol 2016;50:135-9. [PMID: 26997447 DOI: 10.1016/j.humpath.2015.12.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
19 Sheybani A, Gaba RC, Lokken RP, Berggruen SM, Mar WA. Liver Masses: What Physicians Need to Know About Ordering and Interpreting Liver Imaging. Curr Gastroenterol Rep 2017;19:58. [PMID: 29044439 DOI: 10.1007/s11894-017-0596-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
20 Louie CY, Concepcion W, Park JK, Rangaswami A, Finegold MJ, Hazard FK. Hepatoblastoma Arising in a Pigmented β-catenin-activated Hepatocellular Adenoma: Case Report and Review of the Literature. Am J Surg Pathol 2016;40:998-1003. [PMID: 27096257 DOI: 10.1097/PAS.0000000000000652] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
21 Kumagawa M, Matsumoto N, Watanabe Y, Hirayama M, Miura T, Nakagawara H, Ogawa M, Matsuoka S, Moriyama M, Takayama T, Sugitani M. Contrast-enhanced ultrasonographic findings of serum amyloid A-positive hepatocellular neoplasm: Does hepatocellular adenoma arise in cirrhotic liver? World J Hepatol 2016; 8(26): 1110-1115 [PMID: 27660679 DOI: 10.4254/wjh.v8.i26.1110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
22 Marín Camero N, Fernández Aguilar JL, Sánchez Pérez B, Suárez Muñoz MÁ, Santoyo Santoyo J. De la hiperplasia nodular focal al adenoma inflamatorio hepático. Cirugía Española 2012;90:200-1. [DOI: 10.1016/j.ciresp.2010.12.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
23 Fowler KJ, Brown JJ, Narra VR. Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis. Hepatology. 2011;54:2227-2237. [PMID: 21932400 DOI: 10.1002/hep.24679] [Cited by in Crossref: 71] [Cited by in F6Publishing: 58] [Article Influence: 7.1] [Reference Citation Analysis]
24 Lim K, Han C, Dai Y, Shen M, Wu T. Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2. Mol Cancer Ther. 2009;8:3046-3055. [PMID: 19887546 DOI: 10.1158/1535-7163.MCT-09-055] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Lin DC, Mayakonda A, Dinh HQ, Huang P, Lin L, Liu X, Ding LW, Wang J, Berman BP, Song EW, Yin D, Koeffler HP. Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma. Cancer Res. 2017;77:2255-2265. [PMID: 28302680 DOI: 10.1158/0008-5472.can-16-2822] [Cited by in Crossref: 91] [Cited by in F6Publishing: 57] [Article Influence: 18.2] [Reference Citation Analysis]
26 Bambha K, Nagorney D, Sanderson S, Gores GJ. Hepatic adenomatosis in a young woman with glucose intolerance. Nat Clin Pract Gastroenterol Hepatol 2006;3:526-31; quiz (following 531). [PMID: 16951669 DOI: 10.1038/ncpgasthep0576] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
27 Khemlina G, Ikeda S, Kurzrock R. The biology of Hepatocellular carcinoma: implications for genomic and immune therapies. Mol Cancer. 2017;16:149. [PMID: 28854942 DOI: 10.1186/s12943-017-0712-x] [Cited by in Crossref: 117] [Cited by in F6Publishing: 113] [Article Influence: 23.4] [Reference Citation Analysis]
28 van Sprundel RG, van den Ingh TS, Desmet VJ, Katoonizadeh A, Penning LC, Rothuizen J, Roskams T, Spee B. Keratin 19 marks poor differentiation and a more aggressive behaviour in canine and human hepatocellular tumours. Comp Hepatol. 2010;9:4. [PMID: 20167095 DOI: 10.1186/1476-5926-9-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
29 Cox VL, Bhosale P, Varadhachary GR, Wagner-bartak N, Glitza IC, Gold KA, Atkins JT, Soliman PT, Hong DS, Qayyum A. Cancer Genomics and Important Oncologic Mutations: A Contemporary Guide for Body Imagers. Radiology 2017;283:314-40. [DOI: 10.1148/radiol.2017152224] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
30 Dietrich CF, Tannapfel A, Jang H, Kim TK, Burns PN, Dong Y. Ultrasound Imaging of Hepatocellular Adenoma Using the New Histology Classification. Ultrasound in Medicine & Biology 2019;45:1-10. [DOI: 10.1016/j.ultrasmedbio.2018.06.015] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
31 Bellamy C, Burt AD. The Liver in Systemic Disease. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 966-1018. [DOI: 10.1016/b978-0-7020-6697-9.00015-7] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
32 Gaddikeri S, Mcneeley MF, Wang CL, Bhargava P, Dighe MK, Yeh MMC, Dubinsky TJ, Kolokythas O, Lalwani N. Hepatocellular Carcinoma in the Noncirrhotic Liver. American Journal of Roentgenology 2014;203:W34-47. [DOI: 10.2214/ajr.13.11511] [Cited by in Crossref: 49] [Cited by in F6Publishing: 21] [Article Influence: 6.1] [Reference Citation Analysis]
33 Guiu B, Loffroy R, Ben Salem D, Masson D, Hervé G, Petit J, Krausé D, Cercueil J. Stéatose hépatique et séquence phase- opposition de phase : aspects théoriques et applications pratiques à 3T. Journal de Radiologie 2007;88:1845-53. [DOI: 10.1016/s0221-0363(07)78362-2] [Cited by in Crossref: 6] [Article Influence: 0.4] [Reference Citation Analysis]
34 Liau SS, Qureshi MS, Praseedom R, Huguet E. Molecular pathogenesis of hepatic adenomas and its implications for surgical management. J Gastrointest Surg. 2013;17:1869-1882. [PMID: 23835731 DOI: 10.1007/s11605-013-2274-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
35 Graziadei I. [Overview: liver tumors]. Wien Med Wochenschr 2013;163:109-12. [PMID: 23361850 DOI: 10.1007/s10354-013-0177-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
36 Evason KJ, Francisco MT, Juric V, Balakrishnan S, Lopez Pazmino Mdel P, Gordan JD, Kakar S, Spitsbergen J, Goga A, Stainier DY. Identification of Chemical Inhibitors of β-Catenin-Driven Liver Tumorigenesis in Zebrafish. PLoS Genet 2015;11:e1005305. [PMID: 26134322 DOI: 10.1371/journal.pgen.1005305] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 6.1] [Reference Citation Analysis]
37 De Vito C, Papathomas G T, Pedica F, Kane P, Amir A, Heaton N, Quaglia A. Synchronous Unicentric Castleman Disease and Inflammatory Hepatocellular Adenoma: a Case Report. Ann Hepatol 2019;18:263-8. [PMID: 31113603 DOI: 10.5604/01.3001.0012.7936] [Reference Citation Analysis]
38 Sempoux C, Balabaud C, Bioulac-Sage P. Pictures of focal nodular hyperplasia and hepatocellular adenomas. World J Hepatol 2014; 6(8): 580-595 [PMID: 25232451 DOI: 10.4254/wjh.v6.i8.580] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
39 Tan X, Yuan Y, Zeng G, Apte U, Thompson MD, Cieply B, Stolz DB, Michalopoulos GK, Kaestner KH, Monga SP. Beta-catenin deletion in hepatoblasts disrupts hepatic morphogenesis and survival during mouse development. Hepatology 2008;47:1667-79. [PMID: 18393386 DOI: 10.1002/hep.22225] [Cited by in Crossref: 132] [Cited by in F6Publishing: 121] [Article Influence: 9.4] [Reference Citation Analysis]
40 Sempoux C, Balabaud C, Bioulac-Sage P. Malignant transformation of hepatocellular adenoma. Hepat Oncol. 2014;1:421-431. [PMID: 30190977 DOI: 10.2217/hep.14.14] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
41 Shao N, Pandey A, Ghasabeh MA, Khoshpouri P, Pandey P, Varzaneh FN, Zarghampour M, Fouladi D, Pawlik TM, Anders RA, Kamel IR. Long-term follow-up of hepatic adenoma and adenomatosis: analysis of size change on imaging with histopathological correlation. Clin Radiol 2018;73:958-65. [PMID: 30031588 DOI: 10.1016/j.crad.2018.06.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
42 Fonseca S, Hoton D, Dardenne S, Annet L, Hubert C, Godecharles S, Jouret-Mourin A, Reding R, Otte JB, Rahier J, Gigot JF, Sempoux C. Histological and immunohistochemical revision of hepatocellular adenomas: a learning experience. Int J Hepatol 2013;2013:398308. [PMID: 23533787 DOI: 10.1155/2013/398308] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
43 Borgia M, Dal Bo M, Toffoli G. Role of Virus-Related Chronic Inflammation and Mechanisms of Cancer Immune-Suppression in Pathogenesis and Progression of Hepatocellular Carcinoma. Cancers (Basel) 2021;13:4387. [PMID: 34503196 DOI: 10.3390/cancers13174387] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 Ilboudo A, Nault JC, Dubois-Pot-Schneider H, Corlu A, Zucman-Rossi J, Samson M, Le Seyec J. Overexpression of phosphatidylinositol 4-kinase type IIIα is associated with undifferentiated status and poor prognosis of human hepatocellular carcinoma. BMC Cancer. 2014;14:7. [PMID: 24393405 DOI: 10.1186/1471-2407-14-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
45 Dokmak S, Cauchy F, Belghiti J. Resection, transplantation and local regional therapies for liver adenomas. Expert Rev Gastroenterol Hepatol 2014;8:803-10. [PMID: 24957321 DOI: 10.1586/17474124.2014.917957] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
46 Grieser C, Steffen IG, Kramme IB, Bläker H, Kilic E, Perez Fernandez CM, Seehofer D, Schott E, Hamm B, Denecke T. Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience. Eur Radiol 2014;24:1339-48. [PMID: 24658870 DOI: 10.1007/s00330-014-3144-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
47 Chiba T, Zheng Y, Kita K, Yokosuka O, Saisho H, Onodera M, Miyoshi H, Nakano M, Zen Y, Nakanuma Y, Nakauchi H, Iwama A, Taniguchi H. Enhanced Self-Renewal Capability in Hepatic Stem/Progenitor Cells Drives Cancer Initiation. Gastroenterology 2007;133:937-50. [DOI: 10.1053/j.gastro.2007.06.016] [Cited by in Crossref: 156] [Cited by in F6Publishing: 153] [Article Influence: 10.4] [Reference Citation Analysis]
48 Audard V, Grimber G, Elie C, Radenen B, Audebourg A, Letourneur F, Soubrane O, Vacher-Lavenu MC, Perret C, Cavard C. Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations. J Pathol. 2007;212:345-352. [PMID: 17487939 DOI: 10.1002/path.2169] [Cited by in Crossref: 94] [Cited by in F6Publishing: 87] [Article Influence: 6.3] [Reference Citation Analysis]
49 Stoot JH, Coelen RJ, De Jong MC, Dejong CH. Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford). 2010;12:509-522. [PMID: 20887318 DOI: 10.1111/j.1477-2574.2010.00222.x] [Cited by in Crossref: 212] [Cited by in F6Publishing: 183] [Article Influence: 19.3] [Reference Citation Analysis]
50 Liu J, Sui J, Sun D, Guo K, Gao Z, Bian J, Yan J, Wang L. Case Report: An Undefined Liver Lesion in a Young Man With Severe Aplastic Anemia: A Teachable Moment. Front Surg 2021;8:665367. [PMID: 34336914 DOI: 10.3389/fsurg.2021.665367] [Reference Citation Analysis]
51 de'Angelis N, Memeo R, Calderaro J, Felli E, Salloum C, Compagnon P, Luciani A, Laurent A, Cherqui D, Azoulay D. Open and laparoscopic resection of hepatocellular adenoma: trends over 23 years at a specialist hepatobiliary unit. HPB (Oxford). 2014;16:783-788. [PMID: 24852081 DOI: 10.1111/hpb.12257] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
52 Evason KJ, Grenert JP, Ferrell LD, Kakar S. Atypical hepatocellular adenoma-like neoplasms with β-catenin activation show cytogenetic alterations similar to well-differentiated hepatocellular carcinomas. Hum Pathol. 2013;44:750-758. [PMID: 23084586 DOI: 10.1016/j.humpath.2012.07.019] [Cited by in Crossref: 58] [Cited by in F6Publishing: 41] [Article Influence: 5.8] [Reference Citation Analysis]
53 Guyader D, Latournerie M. [Incidental ultrasound finding of a 3 cm liver nodule in a 45-year-old woman taking hormonal substitution after hysterectomy performed for cervix carcinoma]. Gastroenterol Clin Biol 2009;33:F60-7. [PMID: 19766417 DOI: 10.1016/j.gcb.2009.08.006] [Reference Citation Analysis]
54 Witjes CD, ten Kate FJ, Verhoef C, de Man RA, IJzermans JN. Immunohistochemical characteristics of hepatocellular carcinoma in non-cirrhotic livers. J Clin Pathol. 2013;66:687-691. [PMID: 23585667 DOI: 10.1136/jclinpath-2012-201156] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
55 Pacheco MC, Monroe EJ, Horslen SP. Hepatic Adenoma Arising in a Patient With Alagille Syndrome: A Case Report. Pediatr Dev Pathol. 2018;21:585-589. [PMID: 29516774 DOI: 10.1177/1093526618762550] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
56 Kim H, Park YN. Hepatocellular adenomas: recent updates. J Pathol Transl Med 2021;55:171-80. [PMID: 33823565 DOI: 10.4132/jptm.2021.02.27] [Reference Citation Analysis]
57 Ding CH, Deng LF, Chen F, Ding K, Chen WS, Xie WF, Zhang X. p.Q511L mutation of HNF1α in hepatocellular carcinoma suppresses the transcriptional activity and the anti-tumor effect of HNF1α. Biochem Biophys Res Commun 2018;495:86-91. [PMID: 29101032 DOI: 10.1016/j.bbrc.2017.10.174] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
58 Roncalli M, Sciarra A, Tommaso LD. Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma. Clin Mol Hepatol 2016;22:199-211. [PMID: 27189732 DOI: 10.3350/cmh.2016.0101] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
59 Sugimoto K, Kondo F, Furuichi Y, Oshiro H, Nagao T, Saito K, Yoshida H, Imai Y, Fukusato T, Moriyasu F. Focal nodular hyperplasia-like lesion of the liver with focal adenoma features associated with idiopathic portal hypertension. Hepatol Res 2014;44:E309-15. [PMID: 24397430 DOI: 10.1111/hepr.12273] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
60 Young AL, Adair R, Prasad KR, Toogood GJ, Lodge JP. Hepatocellular carcinoma within a noncirrhotic, nonfibrotic, seronegative liver: surgical approaches and outcomes. J Am Coll Surg 2012;214:174-83. [PMID: 22137823 DOI: 10.1016/j.jamcollsurg.2011.10.005] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 3.3] [Reference Citation Analysis]
61 Grazioli L, Olivetti L, Mazza G, Bondioni MP. MR Imaging of Hepatocellular Adenomas and Differential Diagnosis Dilemma. Int J Hepatol 2013;2013:374170. [PMID: 23606972 DOI: 10.1155/2013/374170] [Cited by in Crossref: 44] [Cited by in F6Publishing: 27] [Article Influence: 4.9] [Reference Citation Analysis]
62 Kneuertz PJ, Marsh JW, de Jong MC, Covert K, Hyder O, Hirose K, Schulick RD, Choti MA, Geller DA, Pawlik TM. Improvements in quality of life after surgery for benign hepatic tumors: Results from a dual center analysis. Surgery 2012;152:193-201. [DOI: 10.1016/j.surg.2012.05.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
63 Thoolen B, Ten Kate FJ, van Diest PJ, Malarkey DE, Elmore SA, Maronpot RR. Comparative histomorphological review of rat and human hepatocellular proliferative lesions. J Toxicol Pathol 2012;25:189-99. [PMID: 22988337 DOI: 10.1293/tox.25.189] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
64 Kahn ME, French S, Wang HL. Hepatocellular Adenoma: Morphological and Molecular Variants and Distinction From Well-Differentiated Hepatocellular Carcinoma. Pathology Case Reviews 2009;14:13-20. [DOI: 10.1097/pcr.0b013e31819c4956] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
65 Blanc JF, Frulio N, Chiche L, Bioulac-Sage P, Balabaud C. Hepatocellular adenoma management: advances but still a long way to go. Hepat Oncol. 2015;2:171-180. [PMID: 30190996 DOI: 10.2217/hep.14.41] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
66 Torbenson M, Washington K. Pathology of liver disease: advances in the last 50 years. Hum Pathol 2020;95:78-98. [PMID: 31493428 DOI: 10.1016/j.humpath.2019.08.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
67 Cheng L, Jain D, Kakar S, Torbenson MS, Wu TT, Yeh MM. Hepatocellular neoplasms arising in genetic metabolic disorders: steatosis is common in both the tumor and background liver. Hum Pathol 2021;108:93-9. [PMID: 33245984 DOI: 10.1016/j.humpath.2020.11.012] [Reference Citation Analysis]
68 Miller GC, Campbell CM, Manoharan B, Bryant R, Cavallucci D, O'Rourke N, Clouston AD. Subclassification of hepatocellular adenomas: practical considerations in the implementation of the Bordeaux criteria. Pathology 2018;50:593-9. [PMID: 30149989 DOI: 10.1016/j.pathol.2018.05.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
69 Rebouissou S, Bioulac-Sage P, Zucman-Rossi J. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol. 2008;48:163-170. [PMID: 17997499 DOI: 10.1016/j.jhep.2007.10.003] [Cited by in Crossref: 166] [Cited by in F6Publishing: 124] [Article Influence: 11.1] [Reference Citation Analysis]
70 Lim K, Han C, Dai Y, Shen M, Wu T. Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2. Mol Cancer Ther. 2009;8:3046-3055. [PMID: 19887546 DOI: 10.1158/1535-7163.mct-09-0551] [Cited by in Crossref: 115] [Cited by in F6Publishing: 57] [Article Influence: 8.8] [Reference Citation Analysis]
71 Bisceglia M, Gatta A, Tomezzoli A, Donataccio M. Multiple spontaneous liver cell adenomas of different types (liver adenomatosis). Adv Anat Pathol 2009;16:172-9. [PMID: 19395881 DOI: 10.1097/PAP.0b013e3181a144a1] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
72 Chopinet S, Beaufrère A, Soubrane O, Cauchy F, Paradis V. Reply to: “Malignant transformation of hepatocellular adenoma”. JHEP Reports 2022;4:100429. [DOI: 10.1016/j.jhepr.2022.100429] [Reference Citation Analysis]
73 Chandan VS, Shah SS, Mounajjed T, Torbenson MS, Wu T. Copper deposition in focal nodular hyperplasia and inflammatory hepatocellular adenoma. J Clin Pathol 2018;71:504-7. [DOI: 10.1136/jclinpath-2017-204820] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
74 Cong WM, Dong H, Tan L, Sun XX, Wu MC. Surgicopathological classification of hepatic space-occupying lesions: A single-center experience with literature review. World J Gastroenterol 2011; 17(19): 2372-2378 [PMID: 21633636 DOI: 10.3748/wjg.v17.i19.2372] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
75 Hale G, Liu X, Hu J, Xu Z, Che L, Solomon D, Tsokos C, Shafizadeh N, Chen X, Gill R, Kakar S. Correlation of exon 3 β-catenin mutations with glutamine synthetase staining patterns in hepatocellular adenoma and hepatocellular carcinoma. Mod Pathol 2016;29:1370-80. [PMID: 27469330 DOI: 10.1038/modpathol.2016.122] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 6.2] [Reference Citation Analysis]
76 Lee SY, Kingham TP, LaGratta MD, Jessurun J, Cherqui D, Jarnagin WR, Kluger MD. PET-avid hepatocellular adenomas: incidental findings associated with HNF1-α mutated lesions. HPB (Oxford) 2016;18:41-8. [PMID: 26776850 DOI: 10.1016/j.hpb.2015.07.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
77 Laurent A, Dokmak S, Nault JC, Pruvot FR, Fabre JM, Letoublon C, Bachellier P, Capussotti L, Farges O, Mabrut JY, Le Treut YP, Ayav A, Suc B, Soubrane O, Mentha G, Popescu I, Montorsi M, Demartines N, Belghiti J, Torzilli G, Cherqui D, Hardwigsen J; AFC-HCA-2013 Study Group. European experience of 573 liver resections for hepatocellular adenoma: a cross-sectional study by the AFC-HCA-2013 study group. HPB (Oxford) 2016;18:748-55. [PMID: 27593592 DOI: 10.1016/j.hpb.2016.06.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
78 Mounajjed T, Yasir S, Aleff PA, Torbenson MS. Pigmented hepatocellular adenomas have a high risk of atypia and malignancy. Mod Pathol 2015;28:1265-74. [PMID: 26205181 DOI: 10.1038/modpathol.2015.83] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
79 Abedian S, Abbasi A, de Boer A, Stricker BH, Bakker SJL, van der Harst P, Sedaghat S, Darvishian M, Ikram MA, Navis G, Dehghan A, Pen I, Stolk RP, Snieder H, Klungel OH, Souverein P, Alizadeh BZ. Effect of metabolic genetic variants on long-term disease comorbidity in patients with type 2 diabetes. Sci Rep 2021;11:2794. [PMID: 33531528 DOI: 10.1038/s41598-021-82276-3] [Reference Citation Analysis]
80 Sapisochin G, Bilbao I, Balsells J, Dopazo C, Caralt M, Lázaro JL, Castells L, Allende H, Charco R. Optimization of liver transplantation as a treatment of intrahepatic hepatocellular carcinoma recurrence after partial liver resection: experience of a single European series. World J Surg 2010;34:2146-54. [PMID: 20411387 DOI: 10.1007/s00268-010-0583-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
81 Bioulac-Sage P, Taouji S, Possenti L, Balabaud C. Hepatocellular adenoma subtypes: the impact of overweight and obesity. Liver Int. 2012;32:1217-1221. [PMID: 22429502 DOI: 10.1111/j.1478-3231.2012.02786.x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 71] [Article Influence: 8.6] [Reference Citation Analysis]
82 Bedossa P, Paradis V, Zucman-rossi J. Cellular and Molecular Techniques. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 88-110. [DOI: 10.1016/b978-0-7020-6697-9.00002-9] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
83 Mittal S, Gopal P, Khatri G, Singal AG. Evaluation and Management of Hepatocellular Adenomas. Clin Liver Dis (Hoboken) 2021;17:57-60. [PMID: 33680436 DOI: 10.1002/cld.949] [Reference Citation Analysis]
84 Katabathina VS, Menias CO, Shanbhogue AK, Jagirdar J, Paspulati RM, Prasad SR. Genetics and imaging of hepatocellular adenomas: 2011 update. Radiographics. 2011;31:1529-1543. [PMID: 21997980 DOI: 10.1148/rg.316115527] [Cited by in Crossref: 106] [Cited by in F6Publishing: 77] [Article Influence: 10.6] [Reference Citation Analysis]
85 Klompenhouwer AJ, de Man RA, Dioguardi Burgio M, Vilgrain V, Zucman-Rossi J, Ijzermans JNM. New insights in the management of Hepatocellular Adenoma. Liver Int 2020;40:1529-37. [PMID: 32464711 DOI: 10.1111/liv.14547] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
86 Ferrell LD. Benign and Malignant Tumors of the Liver. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. Elsevier; 2009. pp. 1291-325. [DOI: 10.1016/b978-141604059-0.50050-3] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
87 Rebouissou S, Imbeaud S, Balabaud C, Boulanger V, Bertrand-Michel J, Tercé F, Auffray C, Bioulac-Sage P, Zucman-Rossi J. HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation. J Biol Chem 2007;282:14437-46. [PMID: 17379603 DOI: 10.1074/jbc.M610725200] [Cited by in Crossref: 96] [Cited by in F6Publishing: 33] [Article Influence: 6.4] [Reference Citation Analysis]
88 Vilgrain V, Raynaud L, Paulatto L, Ronot M. Imaging of liver tumours: What’s new? Liver Int 2020;40:154-9. [DOI: 10.1111/liv.14353] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
89 Sumazin P, Chen Y, Treviño LR, Sarabia SF, Hampton OA, Patel K, Mistretta T, Zorman B, Thompson P, Heczey A, Comerford S, Wheeler DA, Chintagumpala M, Meyers R, Rakheja D, Finegold MJ, Tomlinson G, Parsons DW, López‐terrada D. Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups. Hepatology 2016;65:104-21. [DOI: 10.1002/hep.28888] [Cited by in Crossref: 84] [Cited by in F6Publishing: 77] [Article Influence: 14.0] [Reference Citation Analysis]
90 European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines on the management of benign liver tumours. J Hepatol. 2016;65:386-398. [PMID: 27085809 DOI: 10.1016/j.jhep.2016.04.001] [Cited by in Crossref: 201] [Cited by in F6Publishing: 153] [Article Influence: 33.5] [Reference Citation Analysis]
91 Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J, Sa Cunha A, Rullier A, Cubel G, Couchy G, Imbeaud S. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology. 2007;46:740-748. [PMID: 17663417 DOI: 10.1002/hep.21743] [Cited by in Crossref: 421] [Cited by in F6Publishing: 343] [Article Influence: 28.1] [Reference Citation Analysis]
92 Ronot M, Paradis V, Duran R, Kerbaol A, Vullierme MP, Belghiti J, Valla DC, Vilgrain V. MR findings of steatotic focal nodular hyperplasia and comparison with other fatty tumours. Eur Radiol. 2013;23:914-923. [PMID: 23064717 DOI: 10.1007/s00330-012-2676-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
93 Chálim Rebelo C, Moura DB, Flor de Lima M, Dutra E, Amaral R, Pereira JR, Duarte MA. An Extreme Case of Liver Adenomatosis: Are They All the Same? Gastroenterology Insights 2022;13:68-76. [DOI: 10.3390/gastroent13010008] [Reference Citation Analysis]
94 Bioulac-sage P, Balabaud C, Zucman-rossi J. Les tumeurs hépatocytaires bénignes – des connaissances récentes : de la biologie moléculaire au diagnostic. Gastroentérologie Clinique et Biologique 2008;32:296-303. [DOI: 10.1016/j.gcb.2008.02.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
95 Toiyama Y, Inoue Y, Yasuda H, Yoshiyama S, Araki T, Miki C, Kusunoki M. Hepatocellular adenoma containing hepatocellular carcinoma in a male patient with familial adenomatous polyposis coli: Report of a case. Surg Today 2011;41:1442-6. [PMID: 21922375 DOI: 10.1007/s00595-010-4451-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
96 Sousa CMN, Gadelha PMM, Cartaxo RS, Pedrosa GWH, Honorio RS, Lima JMC, Coelho GR, Coelho CR. Hepatocyte Nuclear Factor 1α-Mutated Hepatocellular Adenomas: An Atypical Presentation. Case Rep Gastroenterol 2017;11:637-42. [PMID: 29282384 DOI: 10.1159/000480376] [Reference Citation Analysis]
97 Peng CW, Yan M, Yu YY, Li JF, Ji J, Cai Q, Liu BY, Zhu ZG. Expression of the new target GS mRNA and protein of Wnt signaling pathway in gastric cancerous tissue. Shijie Huaren Xiaohua Zazhi 2009; 17(17): 1777-1781 [DOI: 10.11569/wcjd.v17.i17.1777] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
98 Bahirwani R, Reddy KR. Review article: the evaluation of solitary liver masses. Aliment Pharmacol Ther. 2008;28:953-965. [PMID: 18643922 DOI: 10.1111/j.1365-2036.2008.03805.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
99 Paradis V. [Liver tumor pathology seminar. Cases 2 and 3]. Ann Pathol 2021;41:439-42. [PMID: 34140194 DOI: 10.1016/j.annpat.2021.05.007] [Reference Citation Analysis]
100 Takayassu TC, Marchiori E, Eiras A, Cabral RF, Cabral FC, Batista RR, Zanetti G, Dias PC. Telangiectatic adenoma - computed tomography and magnetic resonance findings: a case report and review of the literature. Cases J 2009;2:24. [PMID: 19128493 DOI: 10.1186/1757-1626-2-24] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
101 Cai YR, Gong L, Teng XY, Zhang HT, Wang CF, Wei GL, Guo L, Ding F, Liu ZH, Pan QJ, Su Q. Clonality and allelotype analyses of focal nodular hyperplasia compared with hepatocellular adenoma and carcinoma. World J Gastroenterol 2009; 15(37): 4695-4708 [PMID: 19787833 DOI: 10.3748/wjg.15.4695] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
102 Reizine E, Amaddeo G, Pigneur F, Baranes L, Legou F, Mulé S, Zegai B, Roche V, Laurent A, Rahmouni A, Calderaro J, Luciani A. Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions. Eur Radiol 2018;28:4243-53. [PMID: 29721686 DOI: 10.1007/s00330-018-5438-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
103 Agrawal S, Agarwal S, Arnason T, Saini S, Belghiti J. Management of Hepatocellular Adenoma: Recent Advances. Clin Gastroenterol Hepatol. 2015;13:1221-1230. [PMID: 24909909 DOI: 10.1016/j.cgh.2014.05.023] [Cited by in Crossref: 55] [Cited by in F6Publishing: 40] [Article Influence: 6.9] [Reference Citation Analysis]
104 Solbach P, Potthoff A, Raatschen HJ, Soudah B, Lehmann U, Schneider A, Gebel MJ, Manns MP, Vogel A. Testosterone-receptor positive hepatocellular carcinoma in a 29-year old bodybuilder with a history of anabolic androgenic steroid abuse: a case report. BMC Gastroenterol 2015;15:60. [PMID: 25986067 DOI: 10.1186/s12876-015-0288-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
105 Brunt EM, Sempoux C, Bioulac-Sage P. Hepatocellular adenomas: the expanding epidemiology. Histopathology 2021;79:20-2. [PMID: 34115403 DOI: 10.1111/his.14343] [Reference Citation Analysis]
106 Lehrke HD, Van Treeck BJ, Allende D, Denham LJ, Gonzalez RS, Moreira RK, Mounajjed T, Naini BV, Smoot RL, Zreik RT, Jenkins S, Graham RP. Does Argininosuccinate Synthase 1 (ASS1) Immunohistochemistry Predict an Increased Risk of Hemorrhage for Hepatocellular Adenomas? Appl Immunohistochem Mol Morphol 2020;28:464-70. [PMID: 31135443 DOI: 10.1097/PAI.0000000000000774] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
107 Goltz D, Fischer HP. [Hepatocellular tumours in noncirrhotic liver tissue]. Pathologe 2015;36:597-606; quiz 607-8. [PMID: 26496997 DOI: 10.1007/s00292-015-0113-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
108 Nishida T, Tsuneyama K, Fujimoto M, Nomoto K, Hayashi S, Miwa S, Nakajima T, Nakanishi Y, Sasaki Y, Suzuki W. Spontaneous onset of nonalcoholic steatohepatitis and hepatocellular carcinoma in a mouse model of metabolic syndrome. Lab Invest. 2013;93:230-241. [PMID: 23212097 DOI: 10.1038/labinvest.2012.155] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 4.2] [Reference Citation Analysis]
109 Dhanasekaran R, Nault JC, Roberts LR, Zucman-Rossi J. Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy. Gastroenterology 2019;156:492-509. [PMID: 30404026 DOI: 10.1053/j.gastro.2018.11.001] [Cited by in Crossref: 65] [Cited by in F6Publishing: 71] [Article Influence: 16.3] [Reference Citation Analysis]
110 Kim SM, Hwang S, Ahn CS, Kim KH, Moon DB, Ha TY, Song GW, Jung DH, Park GC, Hong SM. Clinicopathological features and post-resection outcomes of hepatocellular adenoma. Ann Hepatobiliary Pancreat Surg 2021;25:25-33. [PMID: 33649251 DOI: 10.14701/ahbps.2021.25.1.25] [Reference Citation Analysis]
111 Hamed MA, Ali SA. Non-viral factors contributing to hepatocellular carcinoma. World J Hepatol. 2013;5:311-322. [PMID: 23805355 DOI: 10.4254/wjh.v.5.i6.311] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
112 Bellizzi AM. Contributions of molecular analysis to the diagnosis and treatment of gastrointestinal neoplasms. Seminars in Diagnostic Pathology 2013;30:329-61. [DOI: 10.1053/j.semdp.2013.11.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
113 Hechtman JF, Abou-Alfa GK, Stadler ZK, Mandelker DL, Roehrl MHA, Zehir A, Vakiani E, Middha S, Klimstra DS, Shia J. Somatic HNF1A mutations in the malignant transformation of hepatocellular adenomas: a retrospective analysis of data from MSK-IMPACT and TCGA. Hum Pathol 2019;83:1-6. [PMID: 30121369 DOI: 10.1016/j.humpath.2018.08.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
114 Shanbhogue AK, Prasad SR, Takahashi N, Vikram R, Sahani DV. Recent advances in cytogenetics and molecular biology of adult hepatocellular tumors: Implications for imaging and management. Radiology. 2011;258:673-693. [PMID: 21339346 DOI: 10.1148/radiol.10100376] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
115 Strathmann J, Paal K, Ittrich C, Krause E, Appel KE, Glauert HP, Buchmann A, Schwarz M. Proteome analysis of chemically induced mouse liver tumors with different genotype. Proteomics 2007;7:3318-31. [DOI: 10.1002/pmic.200600983] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
116 Singh HK, Patkar S, Polnaya AM, Ramadwar M, Goel M. Giant Hepatic Adenoma in a 12-Year-Old Girl. J Gastrointest Cancer 2019;50:156-9. [PMID: 28865036 DOI: 10.1007/s12029-017-9999-5] [Reference Citation Analysis]
117 Sorkin T, Strautnieks S, Foskett P, Peddu P, Thompson RJ, Heaton N, Quaglia A. Multiple β-catenin mutations in hepatocellular lesions arising in Abernethy malformation. Hum Pathol 2016;53:153-8. [PMID: 27038679 DOI: 10.1016/j.humpath.2016.02.025] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
118 Kim GJ, Seok JY, Rhee H, Choi JY, Choi JS, Kim KS, Thung S, Park YN. β-Catenin activated hepatocellular adenoma: a report of three cases in Korea. Gut Liver 2014;8:452-8. [PMID: 25071913 DOI: 10.5009/gnl.2014.8.4.452] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
119 Nguyen TB, Roncalli M, Di Tommaso L, Kakar S. Combined use of heat-shock protein 70 and glutamine synthetase is useful in the distinction of typical hepatocellular adenoma from atypical hepatocellular neoplasms and well-differentiated hepatocellular carcinoma. Mod Pathol. 2016;29:283-292. [PMID: 26769138 DOI: 10.1038/modpathol.2015.162] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
120 Jeannot E, Pogribny IP, Beland FA, Rusyn I. Chronic administration of ethanol leads to an increased incidence of hepatocellular adenoma by promoting H-ras-mutated cells. Cancer Lett 2011;301:161-7. [PMID: 21168264 DOI: 10.1016/j.canlet.2010.11.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
121 Sannier A, Cazejust J, Lequoy M, Cervera P, Scatton O, Rosmorduc O, Wendum D. Liver biopsy for diagnosis of presumed benign hepatocellular lesions lacking magnetic resonance imaging diagnostic features of focal nodular hyperplasia. Liver Int 2016;36:1668-76. [PMID: 26969817 DOI: 10.1111/liv.13113] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
122 Cotta-Pereira RL, Valente LF, De Paula DG, Eiras-Araújo AL, Iglesias AC. Rupture of a hepatic adenoma in a young woman after an abdominal trauma: A case report. World J Gastroenterol 2013; 19(27): 4422-4426 [PMID: 23885157 DOI: 10.3748/wjg.v19.i27.4422] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
123 Nault JC, Mallet M, Pilati C, Calderaro J, Bioulac-Sage P, Laurent C, Laurent A, Cherqui D, Balabaud C, Zucman-Rossi J. High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions. Nat Commun 2013;4:2218. [PMID: 23887712 DOI: 10.1038/ncomms3218] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
124 Chang TT, Thakar D, Weaver VM. Force-dependent breaching of the basement membrane. Matrix Biol 2017;57-58:178-89. [PMID: 28025167 DOI: 10.1016/j.matbio.2016.12.005] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 7.7] [Reference Citation Analysis]
125 Colombo M. Diagnosis of liver nodules within and outside screening programs. Annals of Hepatology 2015;14:304-9. [DOI: 10.1016/s1665-2681(19)31268-2] [Cited by in Crossref: 4] [Article Influence: 0.6] [Reference Citation Analysis]
126 Lefkowitch JH. Hepatobiliary pathology. Curr Opin Gastroenterol 2007;23:221-31. [PMID: 17414836 DOI: 10.1097/MOG.0b013e3280adc92e] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
127 Zech CJ, Bartolozzi C, Bioulac-sage P, Chow PK, Forner A, Grazioli L, Huppertz A, Laumonier H, Min Lee J, Murakami T, Ricke J, Sirlin CB. Consensus Report of the Fifth International Forum for Liver MRI. American Journal of Roentgenology 2013;201:97-107. [DOI: 10.2214/ajr.12.9491] [Cited by in Crossref: 32] [Cited by in F6Publishing: 10] [Article Influence: 3.6] [Reference Citation Analysis]
128 Lee DH, Lee JM. Primary malignant tumours in the non-cirrhotic liver. Eur J Radiol. 2017;95:349-361. [PMID: 28987692 DOI: 10.1016/j.ejrad.2017.08.030] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
129 Vinciguerra M, Carrozzino F, Peyrou M, Carlone S, Montesano R, Benelli R, Foti M. Unsaturated fatty acids promote hepatoma proliferation and progression through downregulation of the tumor suppressor PTEN. J Hepatol. 2009;50:1132-1141. [PMID: 19398230 DOI: 10.1016/j.jhep.2009.01.027] [Cited by in Crossref: 80] [Cited by in F6Publishing: 78] [Article Influence: 6.2] [Reference Citation Analysis]
130 Shafizadeh N, Genrich G, Ferrell L, Kakar S. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up. Human Pathology 2014;45:976-83. [DOI: 10.1016/j.humpath.2013.12.011] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
131 Baranes L, Chiaradia M, Pigneur F, Decaens T, Djabbari M, Zegaï B, Costentin C, Laurent A, Calderaro J, Rahmouni A. Imaging benign hepatocellular tumors: atypical forms and diagnostic traps. Diagn Interv Imaging. 2013;94:677-695. [PMID: 23830777 DOI: 10.1016/j.diii.2013.05.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
132 Pelletier L, Rebouissou S, Vignjevic D, Bioulac-Sage P, Zucman-Rossi J. HNF1α inhibition triggers epithelial-mesenchymal transition in human liver cancer cell lines. BMC Cancer 2011;11:427. [PMID: 21975049 DOI: 10.1186/1471-2407-11-427] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
133 Basturk O, Farris AB, Adsay NV. Immunohistology of the Pancreas, Biliary Tract, and Liver. Diagnostic Immunohistochemistry. Elsevier; 2011. pp. 541-92. [DOI: 10.1016/b978-1-4160-5766-6.00019-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
134 Nault JC, Blanc JF, Moga L, Calderaro J, Dao T, Guiu B, Hocquelet A, Paradis V, Salamé E, de Lédinghen V, Bourlière M, Bureau C, Ganne-Carrié N. NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF BENIGN LIVER TUMOURS. Clin Res Hepatol Gastroenterol 2021;:101765. [PMID: 34333196 DOI: 10.1016/j.clinre.2021.101765] [Reference Citation Analysis]
135 Kim Y, Amini N, He J, Margonis GA, Weiss M, Wolfgang CL, Makary M, Hirose K, Spolverato G, Pawlik TM. National trends in the use of surgery for benign hepatic tumors in the United States. Surgery. 2015;157:1055-1064. [PMID: 25769697 DOI: 10.1016/j.surg.2015.01.015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
136 Liu Y, Zen Y, Yeh MM. Steatohepatitis-Like Changes in Hepatocellular Adenoma. Am J Clin Pathol 2020;154:525-32. [PMID: 32561910 DOI: 10.1093/ajcp/aqaa075] [Reference Citation Analysis]
137 Baroud S, Bastati N, Prosch H, Schima W, Ba-Ssalamah A. [Benign focal hepatic lesions]. Radiologe 2011;51:688-96. [PMID: 21809146 DOI: 10.1007/s00117-010-2127-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
138 Hamada K, Saitoh S, Nishino N, Fukushima D, Techigawara K, Koyanagi R, Horikawa Y, Shiwa Y, Sakuma H, Kondo F. An elderly man with progressive focal nodular hyperplasia. Clin J Gastroenterol 2020;13:413-20. [PMID: 31768882 DOI: 10.1007/s12328-019-01072-9] [Reference Citation Analysis]
139 Takahashi T, Nishida T, Baba H, Hatta H, Imura J, Sutoh M, Toyohara S, Hokao R, Watanabe S, Ogawa H, Uehara H, Tsuneyama K. Histopathological characteristics of glutamine synthetase-positive hepatic tumor lesions in a mouse model of spontaneous metabolic syndrome (TSOD mouse). Mol Clin Oncol 2016;5:267-70. [PMID: 27446562 DOI: 10.3892/mco.2016.924] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
140 Ronot M, Bahrami S, Calderaro J, Valla DC, Bedossa P, Belghiti J, Vilgrain V, Paradis V. Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification. Hepatology. 2011;53:1182-1191. [PMID: 21480324 DOI: 10.1002/hep.24147] [Cited by in Crossref: 148] [Cited by in F6Publishing: 124] [Article Influence: 13.5] [Reference Citation Analysis]
141 Henriet E, Abou Hammoud A, Dupuy J, Dartigues B, Ezzoukry Z, Dugot-senant N, Leste-lasserre T, Pallares-lupon N, Nikolski M, Le Bail B, Blanc J, Balabaud C, Bioulac-sage P, Raymond A, Saltel F. Argininosuccinate synthase 1 (ASS1): A marker of unclassified hepatocellular adenoma and high bleeding risk: Henriet, Abou Hammoud, et al. Hepatology 2017;66:2016-28. [DOI: 10.1002/hep.29336] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 9.6] [Reference Citation Analysis]
142 Paradis V. Hepatocellular Adenomas. Surgical Pathology Clinics 2013;6:311-31. [DOI: 10.1016/j.path.2013.03.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
143 Zimmermann A, Lopez-terrada D. Pathology of Pediatric Liver Tumors. In: Zimmermann A, Perilongo G, editors. Pediatric Liver Tumors. Berlin: Springer Berlin Heidelberg; 2011. pp. 83-112. [DOI: 10.1007/978-3-642-14504-9_9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
144 Schulze K, Imbeaud S, Letouzé E, Alexandrov LB, Calderaro J, Rebouissou S, Couchy G, Meiller C, Shinde J, Soysouvanh F, Calatayud AL, Pinyol R, Pelletier L, Balabaud C, Laurent A, Blanc JF, Mazzaferro V, Calvo F, Villanueva A, Nault JC, Bioulac-Sage P, Stratton MR, Llovet JM, Zucman-Rossi J. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat Genet 2015;47:505-11. [PMID: 25822088 DOI: 10.1038/ng.3252] [Cited by in Crossref: 792] [Cited by in F6Publishing: 772] [Article Influence: 113.1] [Reference Citation Analysis]
145 Pilati C, Letouzé E, Nault JC, Imbeaud S, Boulai A, Calderaro J, Poussin K, Franconi A, Couchy G, Morcrette G. Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation. Cancer Cell. 2014;25:428-441. [PMID: 24735922 DOI: 10.1016/j.ccr.2014.03.005] [Cited by in Crossref: 178] [Cited by in F6Publishing: 147] [Article Influence: 22.3] [Reference Citation Analysis]
146 Bellizzi AM. Immunohistochemistry in Gastroenterohepatopancreatobiliary Epithelial Neoplasia. Surgical Pathology Clinics 2013;6:567-609. [DOI: 10.1016/j.path.2013.06.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
147 Bioulac-Sage P, Balabaud C, Bedossa P, Scoazec JY, Chiche L, Dhillon AP, Ferrell L, Paradis V, Roskams T, Vilgrain V. Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. J Hepatol. 2007;46:521-527. [PMID: 17239484 DOI: 10.1016/j.jhep.2006.12.007] [Cited by in Crossref: 139] [Cited by in F6Publishing: 101] [Article Influence: 9.3] [Reference Citation Analysis]
148 Di Pietropaolo M, Briani C, Pilozzi E, Carbonetti F, David V, Iannicelli E. Gd-EOB-DTPA-Enhanced Magnetic Resonance Findings of a Giant Inflammatory Hepatocellular Adenoma: a Case Report and Review of the Literature. J Gastrointest Cancer 2015;46:421-5. [PMID: 25894634 DOI: 10.1007/s12029-015-9715-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
149 Krützfeldt J, Rösch N, Hausser J, Manoharan M, Zavolan M, Stoffel M. MicroRNA-194 is a target of transcription factor 1 (Tcf1, HNF1α) in adult liver and controls expression of frizzled-6. Hepatology. 2012;55:98-107. [PMID: 21887698 DOI: 10.1002/hep.24658] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
150 Bioulac-Sage P, Laumonier H, Couchy G, Le Bail B, Sa Cunha A, Rullier A, Laurent C, Blanc JF, Cubel G, Trillaud H, Zucman-Rossi J, Balabaud C, Saric J. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 2009;50:481-9. [PMID: 19585623 DOI: 10.1002/hep.22995] [Cited by in Crossref: 317] [Cited by in F6Publishing: 233] [Article Influence: 24.4] [Reference Citation Analysis]
151 van Rosmalen BV, Coelen RJS, Bieze M, van Delden OM, Verheij J, Dejong CHC, van Gulik TM. Systematic review of transarterial embolization for hepatocellular adenomas. British Journal of Surgery 2017;104:823-35. [DOI: 10.1002/bjs.10547] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
152 Monga SP. Role of Wnt/β-catenin signaling in liver metabolism and cancer. Int J Biochem Cell Biol. 2011;43:1021-1029. [PMID: 19747566 DOI: 10.1016/j.biocel.2009.09.001] [Cited by in Crossref: 100] [Cited by in F6Publishing: 108] [Article Influence: 7.7] [Reference Citation Analysis]
153 Paradis V. Hepatocellular Carcinomas: Towards a pathomolecular approach. Liver Int 2021;41 Suppl 1:83-8. [PMID: 34155797 DOI: 10.1111/liv.14867] [Reference Citation Analysis]
154 Berry RS, Gullapalli RR, Wu J, Morris K, Hanson JA. Diffuse glutamine synthetase overexpression restricted to areas of peliosis in a β-catenin-activated hepatocellular adenoma: a potential pitfall in glutamine synthetase interpretation. Virchows Arch 2014;465:241-5. [PMID: 24997695 DOI: 10.1007/s00428-014-1620-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
155 Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, Camerini T, Roayaie S, Schwartz ME, Grazi GL, Adam R, Neuhaus P, Salizzoni M, Bruix J, Forner A, De Carlis L, Cillo U, Burroughs AK, Troisi R, Rossi M, Gerunda GE, Lerut J, Belghiti J, Boin I, Gugenheim J, Rochling F, Van Hoek B, Majno P;  Metroticket Investigator Study Group. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009;10:35-43. [PMID: 19058754 DOI: 10.1016/s1470-2045(08)70284-5] [Cited by in Crossref: 1089] [Cited by in F6Publishing: 444] [Article Influence: 77.8] [Reference Citation Analysis]
156 Clément B, Chêne G, Degos F. A national collection of liver tumours: Lessons learnt from 6 years of biobanking in France. Cancer Letters 2009;286:140-4. [DOI: 10.1016/j.canlet.2009.04.034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
157 Sempoux C, Chang C, Gouw A, Chiche L, Zucman-Rossi J, Balabaud C, Bioulac-Sage P. Benign hepatocellular nodules: what have we learned using the patho-molecular classification. Clin Res Hepatol Gastroenterol. 2013;37:322-327. [PMID: 23876350 DOI: 10.1016/j.clinre.2013.04.008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
158 Paradis V. Benign Liver Tumors: An update. Clinics in Liver Disease 2010;14:719-29. [DOI: 10.1016/j.cld.2010.07.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
159 Ozaki K, Harada K, Terayama N, Matsui O, Saitoh S, Tomimaru Y, Fujii T, Gabata T. Hepatocyte nuclear factor 1α-inactivated hepatocellular adenomas exhibit high (18)F-fludeoxyglucose uptake associated with glucose-6-phosphate transporter inactivation. Br J Radiol 2016;89:20160265. [PMID: 27197745 DOI: 10.1259/bjr.20160265] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
160 Dardenne S, Hubert C, Sempoux C, Annet L, Jouret-Mourin A, Horsmans Y, Van Beers BE, Zech F, Gigot JF. Conservative and operative management of benign solid hepatic tumours: a successful stratified algorithm. Eur J Gastroenterol Hepatol. 2010;22:1337-1344. [PMID: 20683192 DOI: 10.1097/MEG.0b013e32833db907] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
161 Bioulac-Sage P, Balabaud C, Zucman-Rossi J. Will the pathomolecular classification of hepatocellular adenomas improve their clinical management? J Hepatol. 2011;55:8-10. [PMID: 21300118 DOI: 10.1016/j.jhep.2011.01.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
162 Auer TA, Fehrenbach U, Grieser C, Penzkofer T, Geisel D, Schmelzle M, Müller T, Bläker H, Seehofer D, Denecke T. Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation? Eur Radiol 2020;30:3497-506. [PMID: 32086574 DOI: 10.1007/s00330-020-06726-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
163 Trevisani F, Frigerio M, Santi V, Grignaschi A, Bernardi M. Hepatocellular carcinoma in non-cirrhotic liver: a reappraisal. Dig Liver Dis. 2010;42:341-347. [PMID: 19828388 DOI: 10.1016/j.dld.2009.09.002] [Cited by in Crossref: 100] [Cited by in F6Publishing: 93] [Article Influence: 7.7] [Reference Citation Analysis]
164 Rebouissou S, Franconi A, Calderaro J, Letouzé E, Imbeaud S, Pilati C, Nault J, Couchy G, Laurent A, Balabaud C, Bioulac‐sage P, Zucman‐rossi J. Genotype‐phenotype correlation of CTNNB1 mutations reveals different ß‐catenin activity associated with liver tumor progression. Hepatology 2016;64:2047-61. [DOI: 10.1002/hep.28638] [Cited by in Crossref: 127] [Cited by in F6Publishing: 123] [Article Influence: 21.2] [Reference Citation Analysis]
165 Gregory J, Paisant A, Paulatto L, Raynaud L, Bertin C, Kerbaol A, Vullierme MP, Paradis V, Vilgrain V, Ronot M. Limited added value of contrast-enhanced ultrasound over B-mode for the subtyping of hepatocellular adenomas. Eur J Radiol 2020;128:109027. [PMID: 32361381 DOI: 10.1016/j.ejrad.2020.109027] [Reference Citation Analysis]
166 Bioulac-sage P, Balabaud C, Zucman-rossi J. Apport de l’immunohistochimie dans le diagnostic des tumeurs hépatocellulaires bénignes. Annales de Pathologie 2010;30:439-47. [DOI: 10.1016/j.annpat.2010.10.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
167 Roux M, Pigneur F, Baranes L, Calderaro J, Chiaradia M, Decaens T, Kastahian S, Charles-Nelson A, Tselikas L, Costentin C, Laurent A, Azoulay D, Mallat A, Rahmouni A, Luciani A. Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful? Abdom Radiol (NY) 2018;43:1670-81. [PMID: 29110059 DOI: 10.1007/s00261-017-1377-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
168 An SL, Wang LM, Rong WQ, Wu F, Sun W, Yu WB, Feng L, Liu FQ, Tian F, Wu JX. Hepatocellular adenoma with malignant transformation in male patients with non-cirrhotic livers. Chin J Cancer 2015;34:217-24. [PMID: 26058379 DOI: 10.1186/s40880-015-0014-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
169 Laumonier H, Frulio N, Laurent C, Balabaud C, Zucman-Rossi J, Bioulac-Sage P. Focal nodular hyperplasia with major sinusoidal dilatation: a misleading entity. BMJ Case Rep 2010;2010:bcr0920103311. [PMID: 22798311 DOI: 10.1136/bcr.09.2010.3311] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
170 Taimr P, Klompenhouwer AJ, Thomeer MGJ, Hansen BE, Ijzermans JNM, de Man RA, de Knegt RJ. Can point shear wave elastography differentiate focal nodular hyperplasia from hepatocellular adenoma. J Clin Ultrasound 2018;46:380-5. [PMID: 29740826 DOI: 10.1002/jcu.22603] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
171 Ringelhan M, Reisinger F, Yuan D, Weber A, Heikenwalder M. Modeling Human Liver Cancer Heterogeneity: Virally Induced Transgenic Models and Mouse Genetic Models of Chronic Liver Inflammation. Current Protocols in Pharmacology 2014;67. [DOI: 10.1002/0471141755.ph1431s67] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
172 Tse JR, Naini BV, Lu DS, Raman SS. Qualitative and Quantitative Gadoxetic Acid-enhanced MR Imaging Helps Subtype Hepatocellular Adenomas. Radiology 2016;279:118-27. [PMID: 26505921 DOI: 10.1148/radiol.2015142449] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
173 Srirattanapong S, Angthong W, Kim BS, Hayashi PH, Gerber DA, Woosley JT, Peacock J, Ranatunga A, Semelka RC. Liver adenomatosis: serial investigation on MRI. Abdom Imaging 2014;39:269-82. [PMID: 24375021 DOI: 10.1007/s00261-013-0056-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
174 Patitucci C, Couchy G, Bagattin A, Cañeque T, de Reyniès A, Scoazec JY, Rodriguez R, Pontoglio M, Zucman-Rossi J, Pende M, Panasyuk G. Hepatocyte nuclear factor 1α suppresses steatosis-associated liver cancer by inhibiting PPARγ transcription. J Clin Invest 2017;127:1873-88. [PMID: 28394260 DOI: 10.1172/JCI90327] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
175 Bioulac-Sage P, Laumonier H, Laurent C, Zucman-Rossi J, Balabaud C. Hepatocellular adenoma: what is new in 2008. Hepatol Int. 2008;2:316-321. [PMID: 19669260 DOI: 10.1007/s12072-008-9075-0] [Cited by in Crossref: 63] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
176 Nejak-Bowen KN, Monga SP. Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad. Semin Cancer Biol. 2011;21:44-58. [PMID: 21182948 DOI: 10.1016/j.semcancer.2010.12.010] [Cited by in Crossref: 170] [Cited by in F6Publishing: 163] [Article Influence: 14.2] [Reference Citation Analysis]
177 Ba-ssalamah A, Baroud S, Bastati N, Qayyum A. MR Imaging of Benign Focal Liver Lesions. Magnetic Resonance Imaging Clinics of North America 2010;18:403-19. [DOI: 10.1016/j.mric.2010.08.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
178 Chu HH, Moon WS. β-catenin activated hepatocellular adenoma. Clin Mol Hepatol 2013;19:185-9. [PMID: 23837144 DOI: 10.3350/cmh.2013.19.2.185] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
179 Anupindi SA, Biko DM, Ntoulia A, Poznick L, Morgan TA, Darge K, Back SJ. Contrast-enhanced US Assessment of Focal Liver Lesions in Children. RadioGraphics 2017;37:1632-47. [DOI: 10.1148/rg.2017170073] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 5.4] [Reference Citation Analysis]
180 Landi F, De' Angelis N, Scatton O, Vidal X, Ayav A, Muscari F, Dokmak S, Torzilli G, Demartines N, Soubrane O, Cherqui D, Hardwigsen J, Laurent A. Short-term outcomes of laparoscopic vs. open liver resection for hepatocellular adenoma: a multicenter propensity score adjustment analysis by the AFC-HCA-2013 study group. Surg Endosc 2017;31:4136-44. [PMID: 28281121 DOI: 10.1007/s00464-017-5466-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
181 Ovsyannikova AK, Rymar OD, Ivanoshchuk DE, Mikhailova SV, Shakhtshneider EV, Orlov PS, Malakhina ES, Voevoda MI. A Case of Maturity Onset Diabetes of the Young (MODY3) in a Family with a Novel HNF1A Gene Mutation in Five Generations. Diabetes Ther 2018;9:413-20. [PMID: 29222740 DOI: 10.1007/s13300-017-0350-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
182 Haas S, Merkelbach-Bruse S, Justenhoven C, Brauch H, Fischer HP. Expression of xenobiotic and steroid hormone metabolizing enzymes in hepatocellular tumors of the non-cirrhotic liver. Pathol Res Pract. 2009;205:716-725. [PMID: 19596526 DOI: 10.1016/j.prp.2009.06.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
183 Monga SP. β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis. Gastroenterology 2015;148:1294-310. [PMID: 25747274 DOI: 10.1053/j.gastro.2015.02.056] [Cited by in Crossref: 247] [Cited by in F6Publishing: 238] [Article Influence: 35.3] [Reference Citation Analysis]
184 Sasaki M, Yoneda N, Kitamura S, Sato Y, Nakanuma Y. A serum amyloid A-positive hepatocellular neoplasm arising in alcoholic cirrhosis: a previously unrecognized type of inflammatory hepatocellular tumor. Mod Pathol. 2012;25:1584-1593. [PMID: 22766792 DOI: 10.1038/modpathol.2012.114] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
185 Yoneda N, Matsui O, Kitao A, Kozaka K, Gabata T, Sasaki M, Nakanuma Y, Murata K, Tani T. Beta-catenin-activated hepatocellular adenoma showing hyperintensity on hepatobiliary-phase gadoxetic-enhanced magnetic resonance imaging and overexpression of OATP8. Jpn J Radiol. 2012;30:777-782. [PMID: 22911100 DOI: 10.1007/s11604-012-0115-2] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
186 Cannella R, Brancatelli G, Rangaswamy B, Minervini MI, Borhani AA, Furlan A. Enhancement pattern of hepatocellular adenoma (HCA) on MR imaging performed with Gd-EOB-DTPA versus other Gd-based contrast agents (GBCAs): An intraindividual comparison. Eur J Radiol 2019;119:108633. [PMID: 31437747 DOI: 10.1016/j.ejrad.2019.08.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
187 Balabaud C, Laurent C, Frulio N, Marie Christine SP, Le Bail B, Possenti L, Blanc JF, Chiche L, Bioulac-sage P. Repeat surgery in HNF1alpha-inactivated adenomatosis. Clinics and Research in Hepatology and Gastroenterology 2019;43:460-7. [DOI: 10.1016/j.clinre.2018.11.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
188 Shafizadeh N, Kakar S. Diagnosis of well-differentiated hepatocellular lesions: role of immunohistochemistry and other ancillary techniques. Adv Anat Pathol. 2011;18:438-445. [PMID: 21993269 DOI: 10.1097/pap.0b013e318234abb4] [Cited by in Crossref: 57] [Cited by in F6Publishing: 7] [Article Influence: 5.7] [Reference Citation Analysis]
189 Shaked O, Reddy KR. Approach to a Liver Mass. Clinics in Liver Disease 2009;13:193-210. [DOI: 10.1016/j.cld.2009.02.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
190 Waisberg J, Saba GT. Wnt-/-β-catenin pathway signaling in human hepatocellular carcinoma. World J Hepatol 2015; 7(26): 2631-2635 [PMID: 26609340 DOI: 10.4254/wjh.v7.i26.2631] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
191 Bioulac-Sage P, Blanc JF, Rebouissou S, Balabaud C, Zucman-Rossi J. Genotype phenotype classification of hepatocellular adenoma. World J Gastroenterol 2007; 13(19): 2649-2654 [PMID: 17569132 DOI: 10.3748/wjg.v13.i19.2649] [Cited by in CrossRef: 67] [Cited by in F6Publishing: 53] [Article Influence: 4.5] [Reference Citation Analysis]
192 Frulio N, Chiche L, Bioulac-Sage P, Balabaud C. Hepatocellular adenomatosis: what should the term stand for! Clin Res Hepatol Gastroenterol 2014;38:132-6. [PMID: 24126236 DOI: 10.1016/j.clinre.2013.08.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
193 Sekine S, Ogawa R, Ojima H, Kanai Y. Expression of SLCO1B3 is associated with intratumoral cholestasis and CTNNB1 mutations in hepatocellular carcinoma. Cancer Sci 2011;102:1742-7. [PMID: 21615622 DOI: 10.1111/j.1349-7006.2011.01990.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
194 van Malenstein H, van Pelt J, Verslype C. Molecular classification of hepatocellular carcinoma anno 2011. Eur J Cancer. 2011;47:1789-1797. [PMID: 21612914 DOI: 10.1016/j.ejca.2011.04.027] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 5.1] [Reference Citation Analysis]
195 Rebouissou S, Amessou M, Couchy G, Poussin K, Imbeaud S, Pilati C, Izard T, Balabaud C, Bioulac-Sage P, Zucman-Rossi J. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature. 2009;457:200-204. [PMID: 19020503 DOI: 10.1038/nature07475] [Cited by in Crossref: 354] [Cited by in F6Publishing: 316] [Article Influence: 25.3] [Reference Citation Analysis]
196 Wang W, Pan Q, Fuhler GM, Smits R, Peppelenbosch MP. Action and function of Wnt/β-catenin signaling in the progression from chronic hepatitis C to hepatocellular carcinoma. J Gastroenterol 2017;52:419-31. [PMID: 28035485 DOI: 10.1007/s00535-016-1299-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 5.7] [Reference Citation Analysis]
197 Görg C, Kunsch S, Neesse A. Zufallsbefunde in der Abdomensonographie: Charakteristika und klinische Interpretation. Internist 2014;55:998-1018. [DOI: 10.1007/s00108-014-3454-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
198 Low G, Dharmana H, Saravana-Bawan S, Girgis S. Case 235: Hepatic Adenomatosis Due to Inflammatory Adenomas. Radiology 2016;281:639-45. [PMID: 27755934 DOI: 10.1148/radiol.2016150420] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
199 Monga SP. Role of Wnt/β-catenin signaling in liver metabolism and cancer. Int J Biochem Cell Biol. 2011;43:1021-1029. [PMID: 19747566 DOI: 10.1016/j.biocel.2009.09.001s1357-2725(09)00244-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
200 Tran Cao HS, Marcal LP, Mason MC, Yedururi S, Joechle K, Wei SH, Vauthey J. Benign hepatic incidentalomas. Current Problems in Surgery 2019;56:100642. [DOI: 10.1067/j.cpsurg.2019.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
201 Zhang L, Bluth MH, Bhalla A. Molecular Diagnostics in the Neoplasms of the Pancreas, Liver, Gallbladder, and Extrahepatic Biliary Tract: 2018 Update. Clin Lab Med 2018;38:367-84. [PMID: 29776636 DOI: 10.1016/j.cll.2018.03.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
202 Sergi CM. Carcinoma of the Liver in Children and Adolescents. In: Sergi CM, editor. Liver Cancer. Exon Publications; 2021. pp. 1-38. [DOI: 10.36255/exonpublications.livercancer.2021.ch1] [Reference Citation Analysis]
203 Nahm CB, Parker N, Gundara JS, Gill AJ, Bhimani N, Samra JS, Hugh TJ. Management of patients with hepatocellular adenoma: a single-institution experience. ANZ J Surg 2020;90:786-90. [PMID: 31943651 DOI: 10.1111/ans.15648] [Reference Citation Analysis]
204 Kakar S, Evason KJ, Ferrell LD. Well-differentiated hepatocellular neoplasm of uncertain malignant potential: proposal for a new diagnostic category—reply. Human Pathology 2014;45:660-1. [DOI: 10.1016/j.humpath.2013.09.019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
205 Köhler UA, Böhm F, Rolfs F, Egger M, Hornemann T, Pasparakis M, Weber A, Werner S. NF-κB/RelA and Nrf2 cooperate to maintain hepatocyte integrity and to prevent development of hepatocellular adenoma. J Hepatol 2016;64:94-102. [PMID: 26348541 DOI: 10.1016/j.jhep.2015.08.033] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
206 Bioulac-Sage P, Taouji S, Le Bail B, Possenti L, Balabaud C. Value and limits of routine histology alone or combined with glutamine synthetase immunostaining in the diagnosis of hepatocellular adenoma subtypes on surgical specimens. Int J Hepatol. 2013;2013:417323. [PMID: 23509631 DOI: 10.1155/2013/417323] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
207 Montenovo MI, Jalikis FG, Yeh M, Reyes JD. Progression of Hepatic Adenoma to Carcinoma in the Setting of Hepatoportal Sclerosis in HIV Patient: Case Report and Review of the Literature. Case Reports Hepatol 2016;2016:1732069. [PMID: 27812395 DOI: 10.1155/2016/1732069] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
208 Balabaud C, Al-Rabih WR, Chen PJ, Evason K, Ferrell L, Hernandez-Prera JC, Huang SF, Longerich T, Park YN, Quaglia A. Focal Nodular Hyperplasia and Hepatocellular Adenoma around the World Viewed through the Scope of the Immunopathological Classification. Int J Hepatol. 2013;2013:268625. [PMID: 23691331 DOI: 10.1155/2013/268625] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
209 Schulze K, Nault JC, Villanueva A. Genetic profiling of hepatocellular carcinoma using next-generation sequencing. J Hepatol. 2016;65:1031-1042. [PMID: 27262756 DOI: 10.1016/j.jhep.2016.05.035] [Cited by in Crossref: 115] [Cited by in F6Publishing: 122] [Article Influence: 19.2] [Reference Citation Analysis]
210 Gramantieri L, Fornari F, Callegari E, Sabbioni S, Lanza G, Croce CM, Bolondi L, Negrini M. MicroRNA involvement in hepatocellular carcinoma. J Cell Mol Med 2008;12:2189-204. [PMID: 19120703 DOI: 10.1111/j.1582-4934.2008.00533.x] [Cited by in Crossref: 182] [Cited by in F6Publishing: 180] [Article Influence: 14.0] [Reference Citation Analysis]
211 Tward AD, Jones KD, Yant S, Cheung ST, Fan ST, Chen X, Kay MA, Wang R, Bishop JM. Distinct pathways of genomic progression to benign and malignant tumors of the liver. Proc Natl Acad Sci USA. 2007;104:14771-14776. [PMID: 17785413 DOI: 10.1073/pnas.0706578104] [Cited by in Crossref: 141] [Cited by in F6Publishing: 135] [Article Influence: 9.4] [Reference Citation Analysis]
212 Nault JC, Fabre M, Couchy G, Pilati C, Jeannot E, Tran Van Nhieu J, Saint-Paul MC, De Muret A, Redon MJ, Buffet C, Salenave S, Balabaud C, Prevot S, Labrune P, Bioulac-Sage P, Scoazec JY, Chanson P, Zucman-Rossi J. GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation. J Hepatol. 2012;56:184-191. [PMID: 21835143 DOI: 10.1016/j.jhep.2011.07.018] [Cited by in Crossref: 85] [Cited by in F6Publishing: 83] [Article Influence: 7.7] [Reference Citation Analysis]
213 Perrakis A, Müller V, Oeckl K, Adamietz B, Demir R, Hohenberger W, Yedibela S. Indications and Long-Term Outcome after Elective Surgery for Hepatocellular Adenoma. The American Surgeon 2012;78:80-5. [DOI: 10.1177/000313481207800140] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
214 Fleming KE, Wanless IR. Glutamine synthetase expression in activated hepatocyte progenitor cells and loss of hepatocellular expression in congestion and cirrhosis. Liver Int. 2013;33:525-534. [PMID: 23362937 DOI: 10.1111/liv.12099] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
215 Paradis V. [How to classify a benign liver cell tumor in 2008?]. Gastroenterol Clin Biol 2008;32:294-5. [PMID: 18367360 DOI: 10.1016/j.gcb.2008.02.013] [Reference Citation Analysis]
216 Oliveira S, Samba AK, Towbin AJ, Gupta A, Geller JI, Nathan JD, Kohli R. Incidental inflammatory adenoma with β-catenin activation in the setting of paediatric NASH. Pediatr Obes 2018;13:70-3. [PMID: 27780309 DOI: 10.1111/ijpo.12189] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
217 Kakar S, Chen X, Ho C, Burgart LJ, Adeyi O, Jain D, Sahai V, Ferrell LD. Chromosomal abnormalities determined by comparative genomic hybridization are helpful in the diagnosis of atypical hepatocellular neoplasms. Histopathology. 2009;55:197-205. [PMID: 19694827 DOI: 10.1111/j.1365-2559.2009.03343.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
218 Larriba MJ, González-Sancho JM, Barbáchano A, Niell N, Ferrer-Mayorga G, Muñoz A. Vitamin D Is a Multilevel Repressor of Wnt/b-Catenin Signaling in Cancer Cells. Cancers (Basel). 2013;5:1242-1260. [PMID: 24202444 DOI: 10.3390/cancers 5041242] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
219 Kim H, Jang JJ, Kim DS, Yeom BW, Won NH. Clinicopathological analysis of hepatocellular adenoma according to new bordeaux classification: report of eight korean cases. Korean J Pathol 2013;47:411-7. [PMID: 24255628 DOI: 10.4132/KoreanJPathol.2013.47.5.411] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
220 Sherman M. Hepatocellular carcinoma: New and emerging risks. Dig Liver Dis. 2010;42 Suppl 3:S215-S222. [PMID: 20547306 DOI: 10.1016/s1590-8658(10)60508-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
221 van Aalten SM, Thomeer MG, Terkivatan T, Dwarkasing RS, Verheij J, de Man RA, Ijzermans JN. Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology. 2011;261:172-181. [PMID: 21875850 DOI: 10.1148/radiol.11110023] [Cited by in Crossref: 157] [Cited by in F6Publishing: 130] [Article Influence: 14.3] [Reference Citation Analysis]
222 Tonorezos ES, Barnea D, Abou-Alfa GK, Bromberg J, D'Angelica M, Sklar CA, Shia J, Oeffinger KC. Hepatocellular adenoma among adult survivors of childhood and young adult cancer. Pediatr Blood Cancer. 2017;64. [PMID: 27781382 DOI: 10.1002/pbc.26294] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
223 Pelletier L, Rebouissou S, Paris A, Rathahao-paris E, Perdu E, Bioulac-sage P, Imbeaud S, Zucman-rossi J. Loss of hepatocyte nuclear factor 1α function in human hepatocellular adenomas leads to aberrant activation of signaling pathways involved in tumorigenesis. Hepatology 2010;51:557-66. [DOI: 10.1002/hep.23362] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 3.7] [Reference Citation Analysis]
224 Ferrell LD, Kakar S, Terracciano LM, Wee A. Tumours and Tumour-like Lesions of the Liver. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 780-879. [DOI: 10.1016/b978-0-7020-6697-9.00013-3] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
225 Chen X, Yang J, Evans PM, Liu C. Wnt signaling: the good and the bad. Acta Biochim Biophys Sin (Shanghai) 2008;40:577-94. [PMID: 18604449 DOI: 10.1111/j.1745-7270.2008.00440.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
226 Bioulac-Sage P. [Case 1: Hepatocellular adenoma and Case 2: Inflammatory/telangiectasic adenoma]. Ann Pathol 2007;27:86-94. [PMID: 17909463 DOI: 10.1016/s0242-6498(07)91290-0] [Reference Citation Analysis]
227 McKay B, Webber L, Manoharan B, Miller G, Clouston A, Bryant R, Cavallucci D, O'Rourke N. Large size and haemorrhage are not contraindications to laparoscopic resection of hepatocellular adenoma. ANZ J Surg 2020;90:1099-103. [PMID: 31983071 DOI: 10.1111/ans.15702] [Reference Citation Analysis]
228 Deneve JL, Pawlik TM, Cunningham S, Clary B, Reddy S, Scoggins CR, Martin RC, D'Angelica M, Staley CA, Choti MA, Jarnagin WR, Schulick RD, Kooby DA. Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol. 2009;16:640-648. [PMID: 19130136 DOI: 10.1245/s10434-008-0275-6] [Cited by in Crossref: 147] [Cited by in F6Publishing: 109] [Article Influence: 11.3] [Reference Citation Analysis]
229 Weindel M, Zulfiqar M, Bhalla A, Shidham VB. Molecular Diagnostics in the Neoplasms of the Pancreas, Liver, Gall Bladder, and Extrahepatic Biliary Tract. Clinics in Laboratory Medicine 2013;33:875-80. [DOI: 10.1016/j.cll.2013.08.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
230 Klompenhouwer AJ, Alblas M, van Rosmalen BV, Haring MPD, Venema E, Doukas M, Thomeer MGJ, Takkenberg RB, Verheij J, de Meijer VE, van Gulik TM, Lingsma HF, de Man RA, Ijzermans JNM. Development and Validation of a Model to Predict Regression of Large Size Hepatocellular Adenoma. Am J Gastroenterol 2019;114:1292-8. [DOI: 10.14309/ajg.0000000000000182] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
231 Young JR, Graham RP, Venkatesh SK, Kendi AT. 18F-FDG PET/CT of hepatocellular adenoma subtypes and review of literature. Abdom Radiol (NY) 2021;46:2604-9. [PMID: 33555390 DOI: 10.1007/s00261-021-02968-2] [Reference Citation Analysis]
232 Rodríguez-peláez M, Menéndez De Llano R, Varela M. Tumores benignos del hígado. Gastroenterología y Hepatología 2010;33:391-7. [DOI: 10.1016/j.gastrohep.2009.11.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
233 Sasaki M, Yoneda N, Kitamura S, Sato Y, Nakanuma Y. Characterization of hepatocellular adenoma based on the phenotypic classification: The Kanazawa experience. Hepatol Res. 2011;41:982-988. [PMID: 21883740 DOI: 10.1111/j.1872-034x.2011.00851.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 18] [Article Influence: 3.9] [Reference Citation Analysis]
234 Chun YS, Calderaro J, Zucman-rossi J. Synchronous hepatocellular carcinoma and Castleman's disease: The role of the interleukin-6-signaling pathway. Hepatology 2012;56:392-3. [DOI: 10.1002/hep.25857] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
235 Desjonqueres E, Campani C, Marra F, Zucman-Rossi J, Nault JC. Preneoplastic lesions in the liver: Molecular insights and relevance for clinical practice. Liver Int 2022. [PMID: 34982503 DOI: 10.1111/liv.15152] [Reference Citation Analysis]
236 Galuppo R, Ramaiah D, Ponte OM, Gedaly R. Molecular therapies in hepatocellular carcinoma: what can we target? Dig Dis Sci. 2014;59:1688-1697. [PMID: 24573715 DOI: 10.1007/s10620-014-3058-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
237 Husainy MA, Sayyed F, Peddu P. Typical and atypical benign liver lesions: A review. Clin Imaging 2017;44:79-91. [PMID: 28486156 DOI: 10.1016/j.clinimag.2017.05.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
238 Froissart R, Piraud M, Boudjemline AM, Vianey-Saban C, Petit F, Hubert-Buron A, Eberschweiler PT, Gajdos V, Labrune P. Glucose-6-phosphatase deficiency. Orphanet J Rare Dis. 2011;6:27. [PMID: 21599942 DOI: 10.1186/1750-1172-6-27] [Cited by in Crossref: 100] [Cited by in F6Publishing: 82] [Article Influence: 9.1] [Reference Citation Analysis]
239 Ji J, Wang XW. Clinical implications of cancer stem cell biology in hepatocellular carcinoma. Semin Oncol. 2012;39:461-472. [PMID: 22846863 DOI: 10.1053/j.seminoncol.2012.05.011] [Cited by in Crossref: 135] [Cited by in F6Publishing: 131] [Article Influence: 13.5] [Reference Citation Analysis]
240 Balabaud C, Laurent C, Le Bail B, Castain C, Possenti L, Frulio N, Chiche L, Blanc JF, Bioulac-Sage P. Unexpected discovery of small HNF1α-inactivated hepatocellular adenoma in pathological specimens from patients resected for liver tumours. Liver Int 2018;38:1273-9. [PMID: 29265678 DOI: 10.1111/liv.13667] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
241 Goudard Y, Rouquie D, Bertocchi C, Daligand H, Baton O, Lahutte M, Terris B, Baranger B. [Malignant transformation of hepatocellular adenoma in men]. Gastroenterol Clin Biol 2010;34:168-70. [PMID: 20189337 DOI: 10.1016/j.gcb.2010.01.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
242 Liu TC, Vachharajani N, Chapman WC, Brunt EM. Noncirrhotic hepatocellular carcinoma: derivation from hepatocellular adenoma? Clinicopathologic analysis. Mod Pathol 2014;27:420-32. [PMID: 24051694 DOI: 10.1038/modpathol.2013.148] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
243 Cieply B, Zeng G, Proverbs-Singh T, Geller DA, Monga SP. Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene. Hepatology 2009;49:821-31. [PMID: 19101982 DOI: 10.1002/hep.22695] [Cited by in Crossref: 109] [Cited by in F6Publishing: 98] [Article Influence: 8.4] [Reference Citation Analysis]
244 Sanada Y, Mizuta K, Niki T, Tashiro M, Hirata Y, Okada N, Yamada N, Ihara Y, Urahashi T, Soejima Y, Fukusato T, Kondo F. Hepatocellular nodules resulting from congenital extrahepatic portosystemic shunts can differentiate into potentially malignant hepatocellular adenomas. J Hepatobiliary Pancreat Sci 2015;22:746-56. [DOI: 10.1002/jhbp.277] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
245 Blonski W, Kotlyar DS, Forde KA. Non-viral causes of hepatocellular carcinoma. World J Gastroenterol 2010; 16(29): 3603-3615 [PMID: 20677332 DOI: 10.3748/wjg.v16.i29.3603] [Cited by in CrossRef: 107] [Cited by in F6Publishing: 97] [Article Influence: 8.9] [Reference Citation Analysis]
246 Sasaki M, Ikeda T, Hatanaka KC, Nakanuma Y. Hyperplastic hepatocellular nodule with localized hemangiomatosis: A hither-to unrecognized type of hypervascular hepatic lesion. Hepatol Res. 2013;Epub ahead of print. [PMID: 23927680 DOI: 10.1111/hepr.12218] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
247 Bioulac-Sage P, Laumonier H, Cubel G, Rossi JZ, Balabaud C. Hepatic resection for inflammatory hepatocellular adenomas: pathological identification of micronodules expressing inflammatory proteins. Liver Int. 2010;30:149-154. [PMID: 19845852 DOI: 10.1111/j.1478-3231.2009.02098.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
248 Beaufrère A, Paradis V. Hepatocellular adenomas: review of pathological and molecular features. Hum Pathol 2021;112:128-37. [PMID: 33307077 DOI: 10.1016/j.humpath.2020.11.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
249 Margolskee E, Bao F, de Gonzalez AK, Moreira RK, Lagana S, Sireci AN, Sepulveda AR, Remotti H, Lefkowitch JH, Salomao M. Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis. Diagn Pathol. 2016;11:27. [PMID: 26961851 DOI: 10.1186/s13000-016-0475-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
250 Dharmana H, Saravana-bawan S, Girgis S, Low G. Hepatocellular adenoma: imaging review of the various molecular subtypes. Clinical Radiology 2017;72:276-85. [DOI: 10.1016/j.crad.2016.12.020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 3.2] [Reference Citation Analysis]
251 Zucman-rossi J, Villanueva A, Nault J, Llovet JM. Genetic Landscape and Biomarkers of Hepatocellular Carcinoma. Gastroenterology 2015;149:1226-1239.e4. [DOI: 10.1053/j.gastro.2015.05.061] [Cited by in Crossref: 531] [Cited by in F6Publishing: 530] [Article Influence: 75.9] [Reference Citation Analysis]
252 Vilarinho S, Erson-Omay EZ, Mitchell-Richards K, Cha C, Nelson-Williams C, Harmancı AS, Yasuno K, Günel M, Taddei TH. Exome analysis of the evolutionary path of hepatocellular adenoma-carcinoma transition, vascular invasion and brain dissemination. J Hepatol 2017;67:186-91. [PMID: 28323122 DOI: 10.1016/j.jhep.2017.03.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
253 Bioulac-Sage P, Balabaud C, Zucman-Rossi J. Focal nodular hyperplasia, hepatocellular adenomas: past, present, future. Gastroenterol Clin Biol. 2010;34:355-358. [PMID: 20537479 DOI: 10.1016/j.gcb.2010.03.014] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
254 Sasaki M, Nakanuma Y. Overview of hepatocellular adenoma in Japan. Int J Hepatol 2012;2012:648131. [PMID: 22973519 DOI: 10.1155/2012/648131] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
255 Monga SP. Hepatic adenomas: presumed innocent until proven to be beta-catenin mutated. Hepatology. 2006;43:401-404. [PMID: 16496344 DOI: 10.1002/hep.21110] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
256 Mohkam K, Darnis B, Cazauran JB, Rode A, Manichon AF, Ducerf C, Bancel B, Mabrut JY. Polymorphic multiple hepatocellular adenoma including a non-steatotic HNF1α-inactivated variant. Hepatobiliary Pancreat Dis Int 2017;16:552-5. [PMID: 28992889 DOI: 10.1016/S1499-3872(17)60058-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
257 Purysko AS, Remer EM, Veniero JC. Focal liver lesion detection and characterization with GD-EOB-DTPA. Clin Radiol. 2011;66:673-684. [PMID: 21524416 DOI: 10.1016/j.crad.2011.01.014] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
258 Nault JC, Couchy G, Caruso S, Meunier L, Caruana L, Letouzé E, Rebouissou S, Paradis V, Calderaro J, Zucman-Rossi J. Argininosuccinate synthase 1 and periportal gene expression in sonic hedgehog hepatocellular adenomas. Hepatology 2018;68:964-76. [PMID: 29572896 DOI: 10.1002/hep.29884] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
259 Calderaro J, Labrune P, Morcrette G, Rebouissou S, Franco D, Prévot S, Quaglia A, Bedossa P, Libbrecht L, Terracciano L. Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I. J Hepatol. 2013;58:350-357. [PMID: 23046672 DOI: 10.1016/j.jhep.2012.09.030] [Cited by in Crossref: 105] [Cited by in F6Publishing: 94] [Article Influence: 10.5] [Reference Citation Analysis]
260 Larson BK, Guindi M. A Limited Immunohistochemical Panel Can Subtype Hepatocellular Adenomas for Routine Practice. Am J Clin Pathol 2017;147:557-70. [PMID: 28472207 DOI: 10.1093/ajcp/aqx010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
261 Jiang K, Al-Diffhala S, Centeno BA. Primary Liver Cancers-Part 1: Histopathology, Differential Diagnoses, and Risk Stratification. Cancer Control. 2018;25:1073274817744625. [PMID: 29350068 DOI: 10.1177/1073274817744625] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
262 Longerich T, Haller MT, Mogler C, Aulmann S, Lohmann V, Schirmacher P, Brand K. Annexin A2 as a differential diagnostic marker of hepatocellular tumors. Pathol Res Pract. 2011;207:8-14. [PMID: 20971570 DOI: 10.1016/j.prp.2010.09.007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
263 Koya Y, Suzuki T, Tai M, Ichii O, Matsuhashi N, Ejiri Y, Miyazawa M, Shibata M, Harada M, Kumabe T, Nakashima O. Inflammatory Hepatocellular Adenoma with Elevated Serum Protein Induced by Vitamin K Absence/Antagonist-II in Adult Males. Intern Med 2019;58:1739-46. [PMID: 30799343 DOI: 10.2169/internalmedicine.1958-18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
264 Jedrzejko N, Berg KB, Gurung A, MacKenzie S. Tumour to tumour metastasis: case of a carotid body paraganglioma metastatic to a hepatocellular adenoma. BMJ Case Rep 2022;15:e248527. [PMID: 35236704 DOI: 10.1136/bcr-2021-248527] [Reference Citation Analysis]
265 López-Terrada D, Alaggio R, de Dávila MT, Czauderna P, Hiyama E, Katzenstein H, Leuschner I, Malogolowkin M, Meyers R, Ranganathan S, Tanaka Y, Tomlinson G, Fabrè M, Zimmermann A, Finegold MJ; Children's Oncology Group Liver Tumor Committee. Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium. Mod Pathol 2014;27:472-91. [PMID: 24008558 DOI: 10.1038/modpathol.2013.80] [Cited by in Crossref: 128] [Cited by in F6Publishing: 107] [Article Influence: 14.2] [Reference Citation Analysis]
266 Yoneda N, Matsui O, Kitao A, Kozaka K, Kobayashi S, Sasaki M, Yoshida K, Inoue D, Minami T, Gabata T. Benign Hepatocellular Nodules: Hepatobiliary Phase of Gadoxetic Acid-enhanced MR Imaging Based on Molecular Background. Radiographics 2016;36:2010-27. [PMID: 27740898 DOI: 10.1148/rg.2016160037] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 7.5] [Reference Citation Analysis]
267 Buc E, Dupre A, Golffier C, Chabrot P, Flamein R, Dubois A, Pezet D. Positive PET-CT scan in hepatocellular adenoma with concomitant benign liver tumors. Gastroenterol Clin Biol. 2010;34:338-341. [PMID: 20227207 DOI: 10.1016/j.gcb.2010.01.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
268 Laumonier H, Rullier A, Saric J, Balabaud C, Bioulac-Sage P. Unexpected discovery of 2 cases of hepatocyte nuclear factor 1α-mutated infracentimetric adenomatosis. World J Gastroenterol 2008; 14(30): 4830-4833 [PMID: 18720549 DOI: 10.3748/wjg.14.4830] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
269 Li M, Liao H, Wu J, Chen B, Pang R, Huang J, Zhu Y. Long noncoding RNA matrilineal expression gene 3 inhibits hepatocellular carcinoma progression by targeting microRNA-5195-3p and regulating the expression of forkhead box O1. Bioengineered 2021;12:12880-90. [PMID: 34895065 DOI: 10.1080/21655979.2021.2005986] [Reference Citation Analysis]
270 Trout AT, Towbin AJ, Smith EA, Gupta A, Dillman JR. Hepatocyte-specific contrast media: not so simple. Pediatr Radiol. 2018;48:1245-1255. [PMID: 30078050 DOI: 10.1007/s00247-018-4108-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
271 Choi WT, Ramachandran R, Kakar S. Immunohistochemical approach for the diagnosis of a liver mass on small biopsy specimens. Hum Pathol. 2017;63:1-13. [PMID: 28087475 DOI: 10.1016/j.humpath.2016.12.025] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
272 Matos AP, Velloni F, Ramalho M, AlObaidy M, Rajapaksha A, Semelka RC. Focal liver lesions: Practical magnetic resonance imaging approach. World J Hepatol 2015; 7(16): 1987-2008 [PMID: 26261689 DOI: 10.4254/wjh.v7.i16.1987] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 4.7] [Reference Citation Analysis]
273 Hu M, Huang X, Han X, Ji L. Loss of HNF1α Function Contributes to Hepatocyte Proliferation and Abnormal Cholesterol Metabolism via Downregulating miR-122: A Novel Mechanism of MODY3. Diabetes Metab Syndr Obes 2020;13:627-39. [PMID: 32184642 DOI: 10.2147/DMSO.S236915] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
274 Cristiano A, Dietrich A, Spina JC, Ardiles V, de Santibañes E. Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management. Updates Surg 2014;66:9-21. [DOI: 10.1007/s13304-013-0222-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
275 Jeannot E, Wendum D, Paye F, Mourra N, de Toma C, Fléjou JF, Zucman-Rossi J. Hepatocellular adenoma displaying a HNF1alpha inactivation in a patient with familial adenomatous polyposis coli. J Hepatol 2006;45:883-6. [PMID: 17049664 DOI: 10.1016/j.jhep.2006.06.020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
276 Agostini CH, Ribeiro OD, Fernandes A, Caroli-bottino A, Pannain VL. Relevance of morphological features for hepatocellular adenoma classification in pathology practice. Surg Exp Pathol 2020;3. [DOI: 10.1186/s42047-020-00061-4] [Reference Citation Analysis]
277 Agnello F, Ronot M, Valla DC, Sinkus R, Van Beers BE, Vilgrain V. High-b-value diffusion-weighted MR imaging of benign hepatocellular lesions: quantitative and qualitative analysis. Radiology. 2012;262:511-519. [PMID: 22143926 DOI: 10.1148/radiol.11110922] [Cited by in Crossref: 63] [Cited by in F6Publishing: 48] [Article Influence: 5.7] [Reference Citation Analysis]
278 Schirmacher P, Longerich T. Hochdifferenzierte Lebertumoren: Neue Entwicklungen und ihre diagnostische Relevanz. Pathologe 2009;30:200-6. [DOI: 10.1007/s00292-009-1214-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
279 Vanounou T, Groeschl RT, Geller DA, Marsh JW, Gamblin TC. Economic model of observation versus immediate resection of hepatic adenomas. J Surg Oncol 2012;106:491-7. [PMID: 22442008 DOI: 10.1002/jso.23099] [Reference Citation Analysis]
280 Ishida R, Yano Y, Yamamoto A, Yasutomi E, Hatazawa Y, Hayashi H, Shiomi Y, Gon H, Omiya S, Kanzawa M, Itoh T, Ueda Y, Kodama Y. Beta-catenin-activated hepatocellular adenoma in a male. Clin J Gastroenterol 2021;14:831-5. [PMID: 33651269 DOI: 10.1007/s12328-021-01372-z] [Reference Citation Analysis]
281 González-Sancho JM, Larriba MJ, Muñoz A. Wnt and Vitamin D at the Crossroads in Solid Cancer. Cancers (Basel) 2020;12:E3434. [PMID: 33227961 DOI: 10.3390/cancers12113434] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
282 Adebayo Michael AO, Ko S, Tao J, Moghe A, Yang H, Xu M, Russell JO, Pradhan-Sundd T, Liu S, Singh S, Poddar M, Monga JS, Liu P, Oertel M, Ranganathan S, Singhi A, Rebouissou S, Zucman-Rossi J, Ribback S, Calvisi D, Qvartskhava N, Görg B, Häussinger D, Chen X, Monga SP. Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin Mutations. Cell Metab 2019;29:1135-1150.e6. [PMID: 30713111 DOI: 10.1016/j.cmet.2019.01.002] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 13.0] [Reference Citation Analysis]
283 Wu L, Bi J, Liu L, Zeng Y. Magnetic resonance elastography can predict the development of hepatocellular carcinoma: a meta-analysis and systematic review. J Gastrointest Oncol 2021;12:1215-22. [PMID: 34532081 DOI: 10.21037/jgo-21-196] [Reference Citation Analysis]
284 Poussin K, Pilati C, Couchy G, Calderaro J, Bioulac-Sage P, Bacq Y, Paradis V, Leteurtre E, Sturm N, Ramos J. Biochemical and functional analyses of gp130 mutants unveil JAK1 as a novel therapeutic target in human inflammatory hepatocellular adenoma. Oncoimmunology. 2013;2:e27090. [PMID: 24501689 DOI: 10.4161/onci.27090] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
285 Obaro AE, Ryan SM. Benign liver lesions: grey-scale and contrast-enhanced ultrasound appearances. Ultrasound 2015;23:116-25. [PMID: 27433246 DOI: 10.1177/1742271X15575805] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
286 Boozari B, Kubicka S. [Differentiated therapy of liver tumors]. Internist (Berl) 2010;51:53-62. [PMID: 20062959 DOI: 10.1007/s00108-009-2526-4] [Reference Citation Analysis]
287 Liao YT, Jeng YM, Lee YH, Tsai MK, Hu RH, Ho MC. The occurrence of primary hepatic adenoma in deceased donor renal transplant recipient. Int Braz J Urol 2014;40:118-22. [PMID: 24642158 DOI: 10.1590/S1677-5538.IBJU.2014.01.17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
288 Krause K, Tanabe KK. A Shifting Paradigm in Diagnosis and Management of Hepatic Adenoma. Ann Surg Oncol 2020;27:3330-8. [PMID: 32542565 DOI: 10.1245/s10434-020-08580-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
289 Hahn E, Putra J. Hepatocellular adenoma in the paediatric population: Molecular classification and clinical associations. World J Gastroenterol 2020; 26(19): 2294-2304 [PMID: 32476794 DOI: 10.3748/wjg.v26.i19.2294] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
290 Rougier P, Mitry E, Barbare JC, Taieb J. Hepatocellular carcinoma (HCC): an update. Semin Oncol. 2007;34:S12-S20. [PMID: 17449346 DOI: 10.1053/j.seminoncol.2007.01.007] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 2.6] [Reference Citation Analysis]
291 Doolittle DA, Atwell TD, Sanchez W, Mounajjed T, Hough DM, Schmit GD, Kurup AN. Safety and Outcomes of Percutaneous Biopsy of 61 Hepatic Adenomas. American Journal of Roentgenology 2016;206:871-6. [DOI: 10.2214/ajr.15.15301] [Cited by in Crossref: 7] [Article Influence: 1.2] [Reference Citation Analysis]
292 Heim D, Gil-Ibanez I, Herden J, Parplys AC, Borgmann K, Schmidt-Arras D, Lohse AW, Rose-John S, Wege H. Constitutive gp130 activation rapidly accelerates the transformation of human hepatocytes via an impaired oxidative stress response. Oncotarget 2016;7:55639-48. [PMID: 27489351 DOI: 10.18632/oncotarget.10956] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
293 Bonder A, Afdhal N. Evaluation of liver lesions. Clin Liver Dis 2012;16:271-83. [PMID: 22541698 DOI: 10.1016/j.cld.2012.03.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
294 Bise S, Frulio N, Hocquelet A, Alberti N, Blanc JF, Laurent C, Laumonier H, Balabaud C, Bioulac-Sage P, Trillaud H. New MRI features improve subtype classification of hepatocellular adenoma. Eur Radiol 2019;29:2436-47. [PMID: 30523457 DOI: 10.1007/s00330-018-5784-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
295 Kang HJ, Jeong HJ, Kim SW, Yu E, Lee YJ, Kim SY, Kim J. Hepatocellular Carcinoma Arising in a Huge Hepatocellular Adenoma with Bone Marrow Metaplasia. J Pathol Transl Med 2018;52:226-31. [PMID: 29281780 DOI: 10.4132/jptm.2017.11.12] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
296 Sa Cunha A, Blanc JF, Lazaro E, Mellottee L, Le Bail B, Zucman-Rossi J, Balabaud C, Bioulac-Sage P. Inflammatory syndrome with liver adenomatosis: the beneficial effects of surgical management. Gut. 2007;56:307-309. [PMID: 17303609 DOI: 10.1136/gut.2006.0106245] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
297 Schlageter M, Terracciano LM, D’Angelo S, Sorrentino P. Histopathology of hepatocellular carcinoma. World J Gastroenterol 2014; 20(43): 15955-15964 [PMID: 25473149 DOI: 10.3748/wjg.v20.i43.15955] [Cited by in CrossRef: 113] [Cited by in F6Publishing: 97] [Article Influence: 14.1] [Reference Citation Analysis]
298 Wu HC, Lay IS, Shibu MA, Ho TJ, Cheng SM, Lin CH, Dung TD, Jeng LB, Viswanadha VP, Huang CY. Zanthoxylum avicennae extract enhances GSK-3β to attenuate β-catenin via phosphatase 2A to block metastatic effects of HA22T cells and hepatocellular carcinoma xenografted nude mice. Environ Toxicol 2017;32:2133-43. [PMID: 28548306 DOI: 10.1002/tox.22426] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
299 Ziogas IA, Tasoudis PT, Serifis N, Alexopoulos SP, Montenovo MI, Shingina A. Liver Transplantation for Hepatic Adenoma: A UNOS Database Analysis and Systematic Review of the Literature. Transplant Direct 2022;8:e1264. [PMID: 35018302 DOI: 10.1097/TXD.0000000000001264] [Reference Citation Analysis]
300 Bioulac-Sage P, Sempoux C, Balabaud C. Hepatocellular adenoma: Classification, variants and clinical relevance. Semin Diagn Pathol. 2017;34:112-125. [PMID: 28131467 DOI: 10.1053/j.semdp.2016.12.007] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 7.3] [Reference Citation Analysis]
301 Matkowskyj KA, Bai H, Liao J, Zhang W, Li H, Rao S, Omary R, Yang GY. Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions. Hum Pathol 2014;45:834-43. [PMID: 24656094 DOI: 10.1016/j.humpath.2013.12.002] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
302 Chou JY, Jun HS, Mansfield BC. Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy. Nat Rev Endocrinol 2010;6:676-88. [PMID: 20975743 DOI: 10.1038/nrendo.2010.189] [Cited by in Crossref: 126] [Cited by in F6Publishing: 114] [Article Influence: 10.5] [Reference Citation Analysis]
303 Nault JC, Bioulac-Sage P, Zucman-Rossi J. Hepatocellular benign tumors-from molecular classification to personalized clinical care. Gastroenterology. 2013;144:888-902. [PMID: 23485860 DOI: 10.1053/j.gastro.2013.02.032] [Cited by in Crossref: 199] [Cited by in F6Publishing: 145] [Article Influence: 22.1] [Reference Citation Analysis]
304 Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou S, Zucman-Rossi J. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology. 2008;47:1955-1963. [PMID: 18433021 DOI: 10.1002/hep.22256] [Cited by in Crossref: 497] [Cited by in F6Publishing: 470] [Article Influence: 35.5] [Reference Citation Analysis]
305 Verslype C, Libbrecht L. The diagnostic and therapeutic approach for primary solid liver tumours in adults. Best Practice & Research Clinical Gastroenterology 2007;21:983-96. [DOI: 10.1016/j.bpg.2007.09.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
306 Laumonier H, Cailliez H, Balabaud C, Possenti L, Zucman-Rossi J, Bioulac-Sage P, Trillaud H. Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: correlation with MRI findings. AJR Am J Roentgenol. 2012;199:341-348. [PMID: 22826395 DOI: 10.2214/ajr.11.7046] [Cited by in Crossref: 44] [Cited by in F6Publishing: 17] [Article Influence: 4.4] [Reference Citation Analysis]
307 Inoue M, Takahashi Y, Fujii T, Kitagawa M, Fukusato T. Significance of downregulation of liver fatty acid-binding protein in hepatocellular carcinoma. World J Gastroenterol 2014; 20(46): 17541-17551 [PMID: 25516669 DOI: 10.3748/wjg.v20.i46.17541] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
308 Chopinet S, Cauchy F, Hobeika C, Beaufrère A, Poté N, Farges O, Dokmak S, Bouattour M, Ronot M, Vilgrain V, Paradis V, Soubrane O. Long-term outcomes following resection of hepatocellular adenomas with small foci of malignant transformation or malignant adenomas. JHEP Rep 2021;3:100326. [PMID: 34368664 DOI: 10.1016/j.jhepr.2021.100326] [Reference Citation Analysis]
309 Bioulac-sage P. Les tumeurs hépatocellulaires bénignes, données morphologiques et moléculaires: une nouvelle classification. Acta Endosc 2006;36:335-42. [DOI: 10.1007/bf03006040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
310 Lee JM, Yang J, Newell P, Singh S, Parwani A, Friedman SL, Nejak-Bowen KN, Monga SP. β-Catenin signaling in hepatocellular cancer: Implications in inflammation, fibrosis, and proliferation. Cancer Lett 2014;343:90-7. [PMID: 24071572 DOI: 10.1016/j.canlet.2013.09.020] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 4.7] [Reference Citation Analysis]
311 Drebber U, Dienes HP. [Diagnosis and differential diagnosis of hepatocellular carcinoma]. Pathologe 2006;27:294-9. [PMID: 16767425 DOI: 10.1007/s00292-006-0842-1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
312 Chen WS. Advances in the relationship between microRNA and mechanism of human primary hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2009; 17(12): 1218-1223 [DOI: 10.11569/wcjd.v17.i12.1218] [Reference Citation Analysis]
313 Zhang C, Shi X, Zhao L. Synchronous giant hepatic adenoma in siblings-A case report and brief literature review. Cancer Biol Ther 2016;17:727-31. [PMID: 27096392 DOI: 10.1080/15384047.2016.1177682] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
314 van Aalten SM, Verheij J, Terkivatan T, Dwarkasing RS, de Man RA, Ijzermans JN. Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice. J Hepatol. 2011;55:120-125. [PMID: 21145863 DOI: 10.1016/j.jhep.2010.10.030] [Cited by in Crossref: 74] [Cited by in F6Publishing: 59] [Article Influence: 6.2] [Reference Citation Analysis]
315 Sakellariou S, Morgan Y, Heaton N, Portmann B, Quaglia A, Tobal K. New monoallelic (partial tandem duplication) mutation of HNF1a gene in steatotic hepatocellular adenoma. Eur J Gastroenterol Hepatol 2011;23:623-7. [PMID: 21566527 DOI: 10.1097/MEG.0b013e328347964d] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
316 Klompenhouwer AJ, Bröker MEE, Thomeer MGJ, Gaspersz MP, de Man RA, Ijzermans JNM. Retrospective study on timing of resection of hepatocellular adenoma. British Journal of Surgery 2017;104:1695-703. [DOI: 10.1002/bjs.10594] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
317 Joseph NM, Umetsu SE, Shafizadeh N, Ferrell L, Kakar S. Genomic profiling of well-differentiated hepatocellular neoplasms with diffuse glutamine synthetase staining reveals similar genetics across the adenoma to carcinoma spectrum. Mod Pathol 2019;32:1627-36. [DOI: 10.1038/s41379-019-0282-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
318 Seo JM, Lee SJ, Kim SH, Park CK, Ha SY. Hepatocellular carcinoma arising from hepatocellular adenoma in a hepatitis B virus-associated cirrhotic liver. Clin Radiol. 2012;67:329-333. [PMID: 22079485 DOI: 10.1016/j.crad.2011.09.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
319 Maylee H, Harada K, Igarashi S, Tohda G, Yamamoto M, Ren XS, Osawa T, Hasegawa Y, Takahashi N, Nakanuma Y. Case of telangiectatic/inflammatory hepatocellular adenoma arising in a patient with primary sclerosing cholangitis. Hepatol Res. 2012;42:611-618. [PMID: 22568458 DOI: 10.1111/j.1872-034X.2011.00962.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
320 Lewin M, Vilgrain V. [Radiological diagnosis of benign liver cell tumors]. Gastroenterol Clin Biol 2008;32:304-9; quiz 293, 314. [PMID: 18367357 DOI: 10.1016/j.gcb.2008.02.016] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
321 Raft MB, Jørgensen EN, Vainer B. Gene mutations in hepatocellular adenomas. Histopathology 2015;66:910-21. [PMID: 25195525 DOI: 10.1111/his.12539] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
322 Cavard C, Colnot S, Audard V, Benhamouche S, Finzi L, Torre C, Grimber G, Godard C, Terris B, Perret C. Wnt/beta-catenin pathway in hepatocellular carcinoma pathogenesis and liver physiology. Future Oncol. 2008;4:647-660. [PMID: 18922122 DOI: 10.2217/14796694.4.5.647] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 4.0] [Reference Citation Analysis]
323 Jeannot E, Mellottee L, Bioulac-Sage P, Balabaud C, Scoazec JY, Tran Van Nhieu J, Bacq Y, Michalak S, Buob D, Laurent-Puig P, Rusyn I, Zucman-Rossi J; Groupe d'étude Génétique des Tumeurs Hépatiques (INSERM Network). Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage. Diabetes 2010;59:1836-44. [PMID: 20393147 DOI: 10.2337/db09-1819] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
324 Thomeer MG, Broker M, Verheij J, Doukas M, Terkivatan T, Bijdevaate D, De Man RA, Moelker A, IJzermans JN. Hepatocellular adenoma: when and how to treat? Update of current evidence. Therap Adv Gastroenterol. 2016;9:898-912. [PMID: 27803743 DOI: 10.1177/1756283x16663882] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 4.8] [Reference Citation Analysis]
325 Resaz R, Rosa F, Grillo F, Basso L, Segalerba D, Puglisi A, Bosco MC, Mastracci L, Neumaier CE, Varesio L, Eva A. Characterization of high- and low-risk hepatocellular adenomas by magnetic resonance imaging in an animal model of glycogen storage disease type 1A. Dis Model Mech. 2019;12. [PMID: 30898969 DOI: 10.1242/dmm.038026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
326 Chouhan S, Singh S, Athavale D, Ramteke P, Pandey V, Joseph J, Mohan R, Shetty PK, Bhat MK. Glucose induced activation of canonical Wnt signaling pathway in hepatocellular carcinoma is regulated by DKK4. Sci Rep 2016;6:27558. [PMID: 27272409 DOI: 10.1038/srep27558] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
327 Liu H, Zhao Q, Jin G, Qian Y, Gu Y, Dong H, Lu X, Cong W, Wu M. Unique genetic alterations and clinicopathological features of hepatocellular adenoma in Chinese population. Pathology - Research and Practice 2015;211:918-24. [DOI: 10.1016/j.prp.2015.09.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
328 Lee SY, Kingham TP, LaGratta MD, Jessurun J, Cherqui D, Jarnagin WR, Kluger MD. PET-avid hepatocellular adenomas: incidental findings associated with HNF1-α mutated lesions. HPB (Oxford) 2015. [PMID: 26472264 DOI: 10.1111/hpb.12489] [Reference Citation Analysis]
329 Ros PR, Goodman ZD. Genetics and imaging of hepatocellular adenomas: 2011 update. Invited commentary. Radiographics 2011;31:1543-5; discussion 1545. [PMID: 22103002 DOI: 10.1148/Radiographics.31.6.111543] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
330 Khalaf AM, Fuentes D, Morshid AI, Burke MR, Kaseb AO, Hassan M, Hazle JD, Elsayes KM. Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance. J Hepatocell Carcinoma 2018;5:61-73. [PMID: 29984212 DOI: 10.2147/JHC.S156701] [Cited by in Crossref: 68] [Cited by in F6Publishing: 44] [Article Influence: 17.0] [Reference Citation Analysis]
331 Hamed MA, Ali SA. Non-viral factors contributing to hepatocellular carcinoma. World J Hepatol 2013; 5(6): 311-322 [PMID: 23805355 DOI: 10.4254/wjh.v5.i6.311] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
332 Shanbhogue A, Shah SN, Zaheer A, Prasad SR, Takahashi N, Vikram R. Hepatocellular adenomas: current update on genetics, taxonomy, and management. J Comput Assist Tomogr. 2011;35:159-166. [PMID: 21412084 DOI: 10.1097/RCT.0b013e31820bad61] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
333 Muranushi R, Araki K, Harimoto N, Yokobori T, Hoshino K, Hagiwara K, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Aishima S, Shirabe K. Unclassified hepatocellular adenoma with beta-catenin mutation: a case report. Surg Case Rep 2021;7:46. [PMID: 33580445 DOI: 10.1186/s40792-021-01131-9] [Reference Citation Analysis]
334 van Rosmalen BV, Furumaya A, Klompenhouwer AJ, Tushuizen ME, Braat AE, Reinten RJ, Ligthart MAP, Haring MPD, de Meijer VE, van Voorthuizen T, Takkenberg RB, Dejong CHC, de Man RA, IJzermans JNM, Doukas M, van Gulik TM, Verheij J; Dutch Benign Liver Tumor Group and the PALGA group. Hepatocellular adenoma in men: A nationwide assessment of pathology and correlation with clinical course. Liver Int 2021. [PMID: 34155783 DOI: 10.1111/liv.14989] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
335 Vanhooymissen IJ, Thomeer MG, Braun LM, Gest B, van Koeverden S, Willemssen FE, Hunink M, De Man RA, Ijzermans JN, Dwarkasing RS. Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia: Hepatobiliary Phase of Two Contrast Agents. J Magn Reson Imaging 2019;49:700-10. [DOI: 10.1002/jmri.26227] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
336 Fan Y, Fang X, Tajima A, Geng X, Ranganathan S, Dong H, Trucco M, Sperling MA. Evolution of hepatic steatosis to fibrosis and adenoma formation in liver-specific growth hormone receptor knockout mice. Front Endocrinol (Lausanne). 2014;5:218. [PMID: 25566190 DOI: 10.3389/fendo.2014.00218] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
337 Khanna M, Ramanathan S, Fasih N, Schieda N, Virmani V, McInnes MD. Current updates on the molecular genetics and magnetic resonance imaging of focal nodular hyperplasia and hepatocellular adenoma. Insights Imaging. 2015;6:347-362. [PMID: 25790815 DOI: 10.1007/s13244-015-0399-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
338 Longerich T, Schirmacher P. A new link between cancer and inflammation? Journal of Hepatology 2009;51:230-2. [DOI: 10.1016/j.jhep.2009.03.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
339 Crawford JM, Liu C. Liver and Biliary Tract. Robbins and Cotran Pathologic Basis of Disease. Elsevier; 2010. pp. 833-90. [DOI: 10.1016/b978-1-4377-0792-2.50023-7] [Cited by in Crossref: 10] [Article Influence: 0.8] [Reference Citation Analysis]
340 Choi W, Kakar S. Atypical Hepatocellular Neoplasms: Review of Clinical, Morphologic, Immunohistochemical, Molecular, and Cytogenetic Features. Advances in Anatomic Pathology 2018;25:254-62. [DOI: 10.1097/pap.0000000000000189] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
341 Pastor CM, Müllhaupt B, Stieger B. The Role of Organic Anion Transporters in Diagnosing Liver Diseases by Magnetic Resonance Imaging. Drug Metab Dispos 2014;42:675-84. [DOI: 10.1124/dmd.113.055707] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
342 Takahashi Y, Dungubat E, Kusano H, Ganbat D, Tomita Y, Odgerel S, Fukusato T. Application of Immunohistochemistry in the Pathological Diagnosis of Liver Tumors. Int J Mol Sci 2021;22:5780. [PMID: 34071338 DOI: 10.3390/ijms22115780] [Reference Citation Analysis]
343 Zucman-Rossi J. Molecular classification of hepatocellular carcinoma. Dig Liver Dis 2010;42 Suppl 3:S235-41. [PMID: 20547309 DOI: 10.1016/S1590-8658(10)60511-7] [Cited by in Crossref: 54] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
344 Kalasekar SM, Kotiyal S, Conley C, Phan C, Young A, Evason KJ. Heterogeneous beta-catenin activation is sufficient to cause hepatocellular carcinoma in zebrafish. Biol Open 2019;8:bio047829. [PMID: 31575545 DOI: 10.1242/bio.047829] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
345 Bioulac-sage P, Cubel G, Taouji S, Scoazec J, Leteurtre E, Paradis V, Sturm N, Van Nhieu JT, Wendum D, Bancel B, Ramos J, Paraf F, Saint Paul MC, Michalak S, Fabre M, Guettier C, Le Bail B, Zucman-rossi J, Balabaud C. Immunohistochemical Markers on Needle Biopsies Are Helpful for the Diagnosis of Focal Nodular Hyperplasia and Hepatocellular Adenoma Subtypes. American Journal of Surgical Pathology 2012;36:1691-9. [DOI: 10.1097/pas.0b013e3182653ece] [Cited by in Crossref: 89] [Cited by in F6Publishing: 25] [Article Influence: 8.9] [Reference Citation Analysis]
346 Patnana M, Menias CO, Pickhardt PJ, Elshikh M, Javadi S, Gaballah A, Shaaban AM, Korivi BR, Garg N, Elsayes KM. Liver Calcifications and Calcified Liver Masses: Pattern Recognition Approach on CT. American Journal of Roentgenology 2018;211:76-86. [DOI: 10.2214/ajr.18.19704] [Cited by in Crossref: 18] [Cited by in F6Publishing: 1] [Article Influence: 4.5] [Reference Citation Analysis]
347 Nault JC, Zucman Rossi J. Molecular classification of hepatocellular adenomas. Int J Hepatol. 2013;2013:315947. [PMID: 23401783 DOI: 10.1155/2013/315947] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
348 Zhang Y, Li XM, Zhang FK, Wang BE. Activation of canonical Wnt signaling pathway promotes proliferation and self-renewal of rat hepatic oval cell line WB-F344 in vitroWorld J Gastroenterol 2008; 14(43): 6673-6680 [PMID: 19034970 DOI: 10.3748/wjg.14.6673] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
349 Vilarinho S, Erson-Omay EZ, Harmanci AS, Morotti R, Carrion-Grant G, Baranoski J, Knisely AS, Ekong U, Emre S, Yasuno K. Paediatric hepatocellular carcinoma due to somatic CTNNB1 and NFE2L2 mutations in the setting of inherited bi-allelic ABCB11 mutations. J Hepatol. 2014;61:1178-1183. [PMID: 25016225 DOI: 10.1016/j.jhep.2014.07.003] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
350 Choi WT, Kakar S. Immunohistochemistry in the Diagnosis of Hepatocellular Carcinoma. Gastroenterol Clin North Am. 2017;46:311-325. [PMID: 28506367 DOI: 10.1016/j.gtc.2017.01.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
351 Rebouissou S, Nault JC. Advances in molecular classification and precision oncology in hepatocellular carcinoma. J Hepatol 2020;72:215-29. [PMID: 31954487 DOI: 10.1016/j.jhep.2019.08.017] [Cited by in Crossref: 65] [Cited by in F6Publishing: 83] [Article Influence: 65.0] [Reference Citation Analysis]
352 Walther Z, Jain D. Molecular pathology of hepatic neoplasms: classification and clinical significance. Patholog Res Int. 2011;2011:403929. [PMID: 21559202 DOI: 10.4061/2011/403929] [Cited by in Crossref: 19] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
353 Fukusato T, Soejima Y, Kondo F, Inoue M, Watanabe M, Takahashi Y, Aso T, Uozaki H, Sano K, Sanada Y, Niki T. Preserved or enhanced OATP1B3 expression in hepatocellular adenoma subtypes with nuclear accumulation of β-catenin. Hepatol Res 2015;45:E32-42. [PMID: 25418671 DOI: 10.1111/hepr.12453] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
354 De Carlis L, Di Sandro S, Giacomoni A, Slim A, Lauterio A, Mangoni I, Mihaylov P, Pirotta V, Aseni P, Rampoldi A. Beyond the Milan criteria: what risks for patients with hepatocellular carcinoma progression before liver transplantation? J Clin Gastroenterol. 2012;46:78-86. [PMID: 21897282 DOI: 10.1097/mcg.0b013e31822b36f6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
355 López-terrada D. Hepatoblastoma: New Insights into the Biology of Embryonal Tumors of the Liver. In: Mackinnon Jr AC, editor. Pediatric Neoplasia. Totowa: Humana Press; 2012. pp. 243-58. [DOI: 10.1007/978-1-62703-116-5_11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
356 Hajósi-Kalcakosz S, Dezső K, Bugyik E, Bödör C, Paku S, Pávai Z, Halász J, Schlachter K, Schaff Z, Nagy P. Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors. Diagn Pathol 2012;7:86. [PMID: 22809481 DOI: 10.1186/1746-1596-7-86] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
357 Castain C, Sempoux C, Brunt EM, Causse O, Heitzmann A, Hernandez-prera JC, Le Bail B, Schirmacher P, Thung SN, Balabaud C, Bioulac-sage P. Coexistence of inflammatory hepatocellular adenomas with HNF1α-inactivated adenomas: is there an association? Histopathology 2014;64:890-5. [DOI: 10.1111/his.12326] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
358 Vinciguerra M, Foti M. PTEN at the crossroad of metabolic diseases and cancer in the liver. Annals of Hepatology 2008;7:192-9. [DOI: 10.1016/s1665-2681(19)31848-4] [Cited by in Crossref: 38] [Article Influence: 2.7] [Reference Citation Analysis]
359 Watkins J, Balabaud C, Bioulac-sage P, Sharma D, Dhillon A. Hepatocellular adenoma in advanced-stage fatty liver disease: . European Journal of Gastroenterology & Hepatology 2009;21:932-6. [DOI: 10.1097/meg.0b013e328311a67c] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
360 Turan A, Unlu HA, Karakus E, Yazal Erdem A, Yakut ZI. Atypical β-Catenin Activated Child Hepatocellular Tumor. Pediatr Gastroenterol Hepatol Nutr 2015;18:144-8. [PMID: 26157702 DOI: 10.5223/pghn.2015.18.2.144] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
361 Zucman-rossi J, Amessou M, Bioulac-sage P, Rebouissou S. Identification de mutations activatrices de gp130 dans la tumorigenèse hépatique. Med Sci (Paris) 2008;24:1113-4. [DOI: 10.1051/medsci/200824121113] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
362 Bioulac-sage P, Laumonier H, Balabaud CP. Benign Hepatocellular Tumors. Practical Hepatic Pathology: A Diagnostic Approach. Elsevier; 2011. pp. 473-88. [DOI: 10.1016/b978-0-443-06803-4.00034-4] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
363 Glonnegger H, Schulze M, Kathemann S, Berg S, Füllgraf H, Tannapfel A, Gerner P, Grohmann J, Niemeyer C, Hettmer S. Case Report: Hepatic Adenoma in a Child With a Congenital Extrahepatic Portosystemic Shunt. Front Pediatr 2020;8:501. [PMID: 32984213 DOI: 10.3389/fped.2020.00501] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
364 Paradis V, Champault A, Ronot M, Deschamps L, Valla DC, Vidaud D, Vilgrain V, Belghiti J, Bedossa P. Telangiectatic adenoma: an entity associated with increased body mass index and inflammation. Hepatology. 2007;46:140-146. [PMID: 17596890 DOI: 10.1002/hep.21684] [Cited by in Crossref: 123] [Cited by in F6Publishing: 98] [Article Influence: 8.2] [Reference Citation Analysis]
365 Austinat M, Dunsch R, Wittekind C, Tannapfel A, Gebhardt R, Gaunitz F. Correlation between beta-catenin mutations and expression of Wnt-signaling target genes in hepatocellular carcinoma. Mol Cancer. 2008;7:21. [PMID: 18282277 DOI: 10.1186/1476-4598-7-21] [Cited by in Crossref: 77] [Cited by in F6Publishing: 71] [Article Influence: 5.5] [Reference Citation Analysis]
366 Cassiman D, Libbrecht L, Verslype C, Meersseman W, Troisi R, Zucman-rossi J, Van Vlierberghe H. An adult male patient with multiple adenomas and a hepatocellular carcinoma: Mild Glycogen Storage Disease type Ia. Journal of Hepatology 2010;53:213-7. [DOI: 10.1016/j.jhep.2010.03.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
367 Izu A, Sugitani M, Kinukawa N, Matsumura H, Ogawa M, Moriyama M, Yamazaki S, Takayama T, Hano H, Yao T, Kanda H, Suzuki K, Hayashi S, Ariizumi S, Yamamoto M, Morishita Y, Matsumoto K, Nakamura N, Nakano M. Hepatocellular adenoma, approximately half and predominantly inflammatory subtype, in 38 Japanese patients with several differences in age, gender, and clinical background factors from Western populations. Hepatol Res 2021;51:336-42. [PMID: 33381872 DOI: 10.1111/hepr.13613] [Reference Citation Analysis]
368 Scoazec JY. Hepatocellular adenomas: one step beyond. Gut 2019;68:1140-2. [PMID: 30967413 DOI: 10.1136/gutjnl-2019-318299] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
369 Chang CY, Hernandez-Prera JC, Roayaie S, Schwartz M, Thung SN. Changing epidemiology of hepatocellular adenoma in the United States: review of the literature. Int J Hepatol. 2013;2013:604860. [PMID: 23509632 DOI: 10.1155/2013/604860] [Cited by in Crossref: 56] [Cited by in F6Publishing: 42] [Article Influence: 6.2] [Reference Citation Analysis]
370 Bioulac-Sage P, Sempoux C, Balabaud C. Hepatocellular Adenomas: Morphology and Genomics. Gastroenterol Clin North Am 2017;46:253-72. [PMID: 28506364 DOI: 10.1016/j.gtc.2017.01.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
371 Glockner JF, Lee CU, Mounajjed T. Inflammatory hepatic adenomas: Characterization with hepatobiliary MRI contrast agents. Magn Reson Imaging 2018;47:103-10. [PMID: 29221964 DOI: 10.1016/j.mri.2017.12.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
372 Manichon AF, Bancel B, Durieux-Millon M, Ducerf C, Mabrut JY, Lepogam MA, Rode A. Hepatocellular adenoma: evaluation with contrast-enhanced ultrasound and MRI and correlation with pathologic and phenotypic classification in 26 lesions. HPB Surg 2012;2012:418745. [PMID: 22811588 DOI: 10.1155/2012/418745] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
373 Saldarriaga J, Bisig B, Couchy G, Castain C, Zucman-Rossi J, Balabaud C, Sempoux C, Bioulac-Sage P. Focal β-catenin mutation identified on formalin-fixed and paraffin-embedded inflammatory hepatocellular adenomas. Histopathology 2017;71:989-93. [PMID: 28618047 DOI: 10.1111/his.13283] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
374 Nault JC, Mallet M, Pilati C, Calderaro J, Bioulac-Sage P, Laurent C, Laurent A, Cherqui D, Balabaud C, Zucman-Rossi J. High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions. Nat Commun. 2013;4:2218. [PMID: 23887712 DOI: 10.1038/ncomms3218] [Cited by in Crossref: 362] [Cited by in F6Publishing: 352] [Article Influence: 45.3] [Reference Citation Analysis]
375 Lu D, Han C, Wu T. Microsomal prostaglandin E synthase-1 promotes hepatocarcinogenesis through activation of a novel EGR1/β-catenin signaling axis. Oncogene 2012;31:842-57. [PMID: 21743491 DOI: 10.1038/onc.2011.287] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
376 Deniz K, Umetsu SE, Ferrell L, Yılmaz F, Güllüoğlu M, Sağol Ö, Doğusoy GB, Kırımlıoğlu H, Turhan N, Doran F, Kepil N, Çelikel ÇA, Nart D, Özgüven BY, Ceyran B, Karadağ N, Kır G, Erden E, Yılmaz G, Akyol G. Hepatocellular adenomas in the Turkish population: reclassification according to updated World Health Organization criteria. Histopathology 2021;79:23-33. [PMID: 33406290 DOI: 10.1111/his.14330] [Reference Citation Analysis]
377 Gebhardt R, Coffer PJ. Hepatic autophagy is differentially regulated in periportal and pericentral zones - a general mechanism relevant for other tissues? Cell Commun Signal. 2013;11:21. [PMID: 23531205 DOI: 10.1186/1478-811x-11-21] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
378 Belghiti J, Cauchy F, Paradis V, Vilgrain V. Diagnosis and management of solid benign liver lesions. Nat Rev Gastroenterol Hepatol. 2014;11:737-749. [PMID: 25178878 DOI: 10.1038/nrgastro.2014.151] [Cited by in Crossref: 57] [Cited by in F6Publishing: 42] [Article Influence: 7.1] [Reference Citation Analysis]
379 Piscaglia F, Lencioni R, Sagrini E, Pina CD, Cioni D, Vidili G, Bolondi L. Characterization of focal liver lesions with contrast-enhanced ultrasound. Ultrasound Med Biol. 2010;36:531-550. [PMID: 20350680 DOI: 10.1016/j.ultrasmedbio.2010.01.004] [Cited by in Crossref: 68] [Cited by in F6Publishing: 58] [Article Influence: 5.7] [Reference Citation Analysis]
380 Pilati C, Amessou M, Bihl MP, Balabaud C, Nhieu JT, Paradis V, Nault JC, Izard T, Bioulac-Sage P, Couchy G, Poussin K, Zucman-Rossi J. Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas. J Exp Med. 2011;208:1359-1366. [PMID: 21690253 DOI: 10.1084/jem.20110283] [Cited by in Crossref: 176] [Cited by in F6Publishing: 166] [Article Influence: 16.0] [Reference Citation Analysis]
381 Nault JC. Pathogenesis of hepatocellular carcinoma according to aetiology. Best Pract Res Clin Gastroenterol. 2014;28:937-947. [PMID: 25260319 DOI: 10.1016/j.bpg.2014.08.006] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 5.8] [Reference Citation Analysis]
382 Bedossa P, Bioulac-Sage P, Guettier C, Scoazec JY. [Diagnostic progress in liver tumor pathology]. Ann Pathol 2007;27:80-3. [PMID: 17909460 DOI: 10.1016/s0242-6498(07)91287-0] [Reference Citation Analysis]
383 Zheng J, Sadot E, Vigidal JA, Klimstra DS, Balachandran VP, Kingham TP, Allen PJ, D'Angelica MI, DeMatteo RP, Jarnagin WR, Ventura A. Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing. PLoS One 2018;13:e0200776. [PMID: 30052636 DOI: 10.1371/journal.pone.0200776] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
384 Vernuccio F, Ronot M, Dioguardi Burgio M, Lebigot J, Allaham W, Aubé C, Brancatelli G, Vilgrain V. Uncommon evolutions and complications of common benign liver lesions. Abdom Radiol (NY) 2018;43:2075-96. [PMID: 29260281 DOI: 10.1007/s00261-017-1427-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
385 Goodman ZD, Terracciano LM, Wee A. Tumours and tumour-like lesions of the liver. MacSween's Pathology of the Liver. Elsevier; 2012. pp. 761-851. [DOI: 10.1016/b978-0-7020-3398-8.00014-3] [Cited by in Crossref: 21] [Article Influence: 2.1] [Reference Citation Analysis]
386 Shen XY, Hu XG, Kim YB, Kim MN, Hong SY, Kim BW, Wang HJ. Molecular classification of hepatocellular adenoma: A single-center experience. Ann Hepatobiliary Pancreat Surg 2019;23:109-14. [PMID: 31225410 DOI: 10.14701/ahbps.2019.23.2.109] [Reference Citation Analysis]
387 van Rosmalen BV, Klompenhouwer AJ, de Graeff JJ, Haring MPD, de Meijer VE, Rifai L, Dokmak S, Rawashdeh A, Abu Hilal M, de Jong MC, Dejong CHC, Doukas M, de Man RA, IJzermans JNM, van Delden OM, Verheij J, van Gulik TM; Dutch Benign Liver Tumour Group. Safety and efficacy of transarterial embolization of hepatocellular adenomas. Br J Surg 2019;106:1362-71. [PMID: 31313827 DOI: 10.1002/bjs.11213] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
388 Inaba K, Sakaguchi T, Kurachi K, Mori H, Tao H, Nakamura T, Takehara Y, Baba S, Maekawa M, Sugimura H, Konno H. Hepatocellular adenoma associated with familial adenomatous polyposis coli. World J Hepatol 2012; 4(11): 322-326 [PMID: 23293720 DOI: 10.4254/wjh.v4.i11.322] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
389 Purcell Y, Copin P, Paradis V, Vilgrain V, Ronot M. Lessons learnt from pathologic imaging correlation in the liver: an historical perspective. Br J Radiol 2019;92:20180701. [PMID: 30604641 DOI: 10.1259/bjr.20180701] [Reference Citation Analysis]
390 Shaked O, Siegelman ES, Olthoff K, Reddy KR. Biologic and Clinical Features of Benign Solid and Cystic Lesions of the Liver. Clinical Gastroenterology and Hepatology 2011;9:547-562.e4. [DOI: 10.1016/j.cgh.2011.03.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
391 Védie AL, Sutter O, Ziol M, Nault JC. Molecular classification of hepatocellular adenomas: impact on clinical practice. Hepat Oncol 2018;5:HEP04. [PMID: 30302195 DOI: 10.2217/hep-2017-0023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
392 Reizine E, Ronot M, Ghosn M, Calderaro J, Frulio N, Bioulac-Sage P, Trillaud H, Vilgrain V, Paradis V, Luciani A. Hepatospecific MR contrast agent uptake on hepatobiliary phase can be used as a biomarker of marked β-catenin activation in hepatocellular adenoma. Eur Radiol 2021;31:3417-26. [PMID: 33146794 DOI: 10.1007/s00330-020-07434-z] [Reference Citation Analysis]
393 Garcovich M, Faccia M, Meloni F, Bertolini E, de Sio I, Calabria G, Francica G, Vidili G, Riccardi L, Zocco MA, Ainora ME, Ponziani FR, De Gaetano AM, Gasbarrini A, Rapaccini GL, Pompili M. Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience. J Ultrasound 2019;22:157-65. [PMID: 30306412 DOI: 10.1007/s40477-018-0322-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
394 Nugent TS, Donlon N, Kelly M, Iqbal M, Murphy N, Ryan M, Maguire D. Life-Threatening Intraparenchymal Hemorrhage of Steroid-Induced Hepatic Adenomas in a Healthy Man. ACG Case Rep J 2021;8:e00601. [PMID: 34046510 DOI: 10.14309/crj.0000000000000601] [Reference Citation Analysis]
395 Goltz D, Fischer HP. Current Proceedings in the Molecular Dissection of Hepatocellular Adenomas: Review and Hands-on Guide for Diagnosis. Int J Mol Sci 2015;16:20994-1007. [PMID: 26404250 DOI: 10.3390/ijms160920994] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
396 Cannella R, Rangaswamy B, Minervini MI, Borhani AA, Tsung A, Furlan A. Value of Texture Analysis on Gadoxetic Acid-Enhanced MRI for Differentiating Hepatocellular Adenoma From Focal Nodular Hyperplasia. AJR Am J Roentgenol 2019;212:538-46. [PMID: 30557050 DOI: 10.2214/AJR.18.20182] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
397 DiPaola F, Trout AT, Walther AE, Gupta A, Sheridan R, Campbell KM, Tiao G, Bezerra JA, Bove KE, Patel M, Nathan JD. Congenital Portosystemic Shunts in Children: Associations, Complications, and Outcomes. Dig Dis Sci 2020;65:1239-51. [PMID: 31549332 DOI: 10.1007/s10620-019-05834-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
398 Mercer KE, Hennings L, Sharma N, Lai K, Cleves MA, Wynne RA, Badger TM, Ronis MJ. Alcohol consumption promotes diethylnitrosamine-induced hepatocarcinogenesis in male mice through activation of the Wnt/β-catenin signaling pathway. Cancer Prev Res (Phila) 2014;7:675-85. [PMID: 24778325 DOI: 10.1158/1940-6207.CAPR-13-0444-T] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
399 Begum S. Hepatic Nuclear Factor 1 Alpha (HNF-1α) In Human Physiology and Molecular Medicine. Curr Mol Pharmacol 2020;13:50-6. [PMID: 31566143 DOI: 10.2174/1874467212666190930144349] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
400 Sanada Y, Mizuta K. Congenital absence of the portal vein: translated version. J Hepatobiliary Pancreat Sci 2018;25:359-69. [PMID: 30160060 DOI: 10.1002/jhbp.572] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
401 Belghiti J, Dokmak S, Vilgrain V, Paradis V. Benign liver lesions. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract. Elsevier; 2012. pp. 1250-1267.e4. [DOI: 10.1016/b978-1-4377-1454-8.00079-5] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
402 de Souza DA, Parente DB, de Araújo AL, Mortelé KJ. Modern imaging evaluation of the liver: emerging MR imaging techniques and indications. Magn Reson Imaging Clin N Am 2013;21:337-63. [PMID: 23642557 DOI: 10.1016/j.mric.2013.01.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
403 Zeng G, Apte U, Cieply B, Singh S, Monga SP. siRNA-mediated beta-catenin knockdown in human hepatoma cells results in decreased growth and survival. Neoplasia 2007;9:951-9. [PMID: 18030363 DOI: 10.1593/neo.07469] [Cited by in Crossref: 83] [Cited by in F6Publishing: 84] [Article Influence: 5.5] [Reference Citation Analysis]
404 Magini G, Farsad M, Frigerio M, Serra C, Colecchia A, Jovine E, Vivarelli M, Feletti V, Golfieri R, Patti C. C-11 acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma. Clin Nucl Med. 2009;34:659-665. [PMID: 19893396 DOI: 10.1097/rlu.0b013e3181b53488] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
405 Calderaro J, Nault JC, Balabaud C, Couchy G, Saint-paul M, Azoulay D, Mehdaoui D, Luciani A, Zafrani ES, Bioulac-sage P, Zucman-rossi J. Inflammatory hepatocellular adenomas developed in the setting of chronic liver disease and cirrhosis. Mod Pathol 2016;29:43-50. [DOI: 10.1038/modpathol.2015.119] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
406 Schooler GR, Hull NC, Lee EY. Hepatobiliary MRI Contrast Agents: Pattern Recognition Approach to Pediatric Focal Hepatic Lesions. American Journal of Roentgenology 2020;214:976-86. [DOI: 10.2214/ajr.19.22239] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
407 Pilati C, Zucman-rossi J. Mutations leading to constitutive active gp130/JAK1/STAT3 pathway. Cytokine & Growth Factor Reviews 2015;26:499-506. [DOI: 10.1016/j.cytogfr.2015.07.010] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
408 Tsilimigras DI, Rahnemai-azar AA, Ntanasis-stathopoulos I, Gavriatopoulou M, Moris D, Spartalis E, Cloyd JM, Weber SM, Pawlik TM. Current Approaches in the Management of Hepatic Adenomas. J Gastrointest Surg 2019;23:199-209. [DOI: 10.1007/s11605-018-3917-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
409 Tátrai P, Somorácz A, Batmunkh E, Schirmacher P, Kiss A, Schaff Z, Nagy P, Kovalszky I. Agrin and CD34 immunohistochemistry for the discrimination of benign versus malignant hepatocellular lesions. Am J Surg Pathol. 2009;33:874-885. [PMID: 19194276 DOI: 10.1097/pas.0b013e318194b3ea] [Cited by in Crossref: 42] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
410 Chen PJ. Genetic mutation in hepatic adenoma: seeing is believing. J Hepatol 2006;45:767-9. [PMID: 17034896 DOI: 10.1016/j.jhep.2006.09.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
411 Zucman-rossi J. Human and mouse hepatocellular adenoma and carcinoma display similar tumorigenesis pathway alterations. Journal of Hepatology 2008;48:884-6. [DOI: 10.1016/j.jhep.2008.02.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
412 Kato K, Abe H, Hanawa N, Fukuzawa J, Matsuo R, Yonezawa T, Itoh S, Sato Y, Ika M, Shimizu S, Endo S, Hano H, Izu A, Sugitani M, Tsubota A. Hepatocellular adenoma in a woman who was undergoing testosterone treatment for gender identity disorder. Clin J Gastroenterol. 2018;11:401-410. [PMID: 29589251 DOI: 10.1007/s12328-018-0854-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
413 van Aalten SM, Terkivatan T, van der Linden E, Verheij J, de Man RA, Ijzermans JN. Management of liver adenomatosis by radiofrequency ablation. Dig Surg 2011;28:173-7. [PMID: 21540605 DOI: 10.1159/000323746] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
414 Thompson MD, Monga SP. WNT/beta-catenin signaling in liver health and disease. Hepatology. 2007;45:1298-1305. [PMID: 17464972 DOI: 10.1002/hep.21651] [Cited by in Crossref: 342] [Cited by in F6Publishing: 320] [Article Influence: 22.8] [Reference Citation Analysis]
415 Iguchi T, Yamagata M, Sonoda T, Yanagita K, Fukahori T, Tsujita E, Aishima S, Oda Y, Maehara Y. Malignant transformation of hepatocellular adenoma with bone marrow metaplasia arising in glycogen storage disease type I: A case report. Mol Clin Oncol 2016;5:599-603. [PMID: 27900094 DOI: 10.3892/mco.2016.1034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
416 Herbet M, Feige J, Thomas M. Insights into the role of genetic alterations in adrenocortical tumorigenesis. Molecular and Cellular Endocrinology 2009;300:169-74. [DOI: 10.1016/j.mce.2008.10.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
417 Gordic S, Thung SN, Roayaie S, Wagner M, Taouli B. Hepatic adenomatosis in liver cirrhosis. Eur J Radiol Open 2017;4:115-7. [PMID: 28932768 DOI: 10.1016/j.ejro.2017.08.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
418 Ladeiro Y, Zucman-rossi J. Micro-ARN (miARN) et cancer : le cas des tumeurs hépatocellulaires. Med Sci (Paris) 2009;25:467-72. [DOI: 10.1051/medsci/2009255467] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
419 Nemoto S, Ariizumi SI, Kotera Y, Omori A, Yamashita S, Kato TA, Aoyama S, Egawa H, Yamamoto M. Inflammatory hepatocellular adenoma in a patient with Turner's syndrome: A case report. Int J Surg Case Rep. 2019;56:5-9. [PMID: 30798096 DOI: 10.1016/j.ijscr.2019.02.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
420 Thapar M, Grapp O, Fisher C. Management of hepatic adenomatosis. Curr Gastroenterol Rep 2015;17:12. [PMID: 25740249 DOI: 10.1007/s11894-015-0434-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
421 Ba-Ssalamah A, Antunes C, Feier D, Bastati N, Hodge JC, Stift J, Cipriano MA, Wrba F, Trauner M, Herold CJ, Caseiro-Alves F. Morphologic and Molecular Features of Hepatocellular Adenoma with Gadoxetic Acid-enhanced MR Imaging. Radiology. 2015;277:104-113. [PMID: 25985059 DOI: 10.1148/radiol.2015142366] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 9.6] [Reference Citation Analysis]
422 Kim YI, Lee J, Choi YJ, Seo J, Park J, Lee SY, Cho JY. Proteogenomic Study beyond Chromosome 9: New Insight into Expressed Variant Proteome and Transcriptome in Human Lung Adenocarcinoma Tissues. J Proteome Res 2015;14:5007-16. [PMID: 26584007 DOI: 10.1021/acs.jproteome.5b00544] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
423 Larson BK, Dhall D, Guindi M. Immunohistochemistry as a surrogate for molecular diagnosis in hepatic tumours. Diagnostic Histopathology 2015;21:108-15. [DOI: 10.1016/j.mpdhp.2015.03.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
424 Nault JC, Couchy G, Balabaud C, Morcrette G, Caruso S, Blanc JF, Bacq Y, Calderaro J, Paradis V, Ramos J, Scoazec JY, Gnemmi V, Sturm N, Guettier C, Fabre M, Savier E, Chiche L, Labrune P, Selves J, Wendum D, Pilati C, Laurent A, De Muret A, Le Bail B, Rebouissou S, Imbeaud S, Bioulac-Sage P, Letouzé E, Zucman-Rossi J; GENTHEP Investigators. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation. Gastroenterology 2017;152:880-894.e6. [PMID: 27939373 DOI: 10.1053/j.gastro.2016.11.042] [Cited by in Crossref: 168] [Cited by in F6Publishing: 144] [Article Influence: 28.0] [Reference Citation Analysis]
425 Sempoux C, Gouw ASH, Dunet V, Paradis V, Balabaud C, Bioulac-Sage P. Predictive Patterns of Glutamine Synthetase Immunohistochemical Staining in CTNNB1-mutated Hepatocellular Adenomas. Am J Surg Pathol 2021;45:477-87. [PMID: 33560657 DOI: 10.1097/PAS.0000000000001675] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
426 Reizine E, Ronot M, Pigneur F, Purcell Y, Mulé S, Dioguardi Burgio M, Calderaro J, Amaddeo G, Laurent A, Vilgrain V, Luciani A. Iso- or hyperintensity of hepatocellular adenomas on hepatobiliary phase does not always correspond to hepatospecific contrast-agent uptake: importance for tumor subtyping. Eur Radiol 2019;29:3791-801. [DOI: 10.1007/s00330-019-06150-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
427 Kim JH, Joo I, Lee JM. Atypical Appearance of Hepatocellular Carcinoma and Its Mimickers: How to Solve Challenging Cases Using Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging. Korean J Radiol 2019;20:1019-41. [PMID: 31270973 DOI: 10.3348/kjr.2018.0636] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
428 Zulfiqar M, Sirlin CB, Yoneda N, Ronot M, Hecht EM, Chernyak V, Matsui O, Bastati N, Ba‐ssalamah A, Chatterjee D, Bashir M, Fowler KJ. Hepatocellular adenomas: Understanding the pathomolecular lexicon, MRI features, terminology, and pitfalls to inform a standardized approach. J Magn Reson Imaging 2020;51:1630-40. [DOI: 10.1002/jmri.26902] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
429 Putra J, Ferrell LD, Gouw ASH, Paradis V, Rishi A, Sempoux C, Balabaud C, Thung SN, Bioulac-Sage P. Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon. Mod Pathol. 2020;33:665-675. [PMID: 31570768 DOI: 10.1038/s41379-019-0374-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
430 Jeannot E, Lacape G, Gin H, Couchy G, Saric J, Laumonier H, Le Bail B, Bioulac-Sage P, Balabaud C, Zucman-Rossi J. Double heterozygous germline HNF1A mutations in a patient with liver adenomatosis. Diabetes Care 2012;35:e35. [PMID: 22517943 DOI: 10.2337/dc12-0030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
431 Longerich T, Endris V, Neumann O, Rempel E, Kirchner M, Abadi Z, Uhrig S, Kriegsmann M, Weiss KH, Breuhahn K, Mehrabi A, Weber TF, Wilkens L, Straub BK, Rosenwald A, Schulze F, Brors B, Froehling S, Pellegrino R, Budczies J, Schirmacher P, Stenzinger A. RSPO2 gene rearrangement: a powerful driver of β-catenin activation in liver tumours. Gut 2019;68:1287-96. [PMID: 30901310 DOI: 10.1136/gutjnl-2018-317632] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
432 Brunel T, Guibal A, Boularan C, Ducerf C, Mabrut JY, Bancel B, Boussel L, Rode A. Focal nodular hyperplasia and hepatocellular adenoma: The value of shear wave elastography for differential diagnosis. Eur J Radiol. 2015;84:2059-2064. [PMID: 26299323 DOI: 10.1016/j.ejrad.2015.07.029] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
433 Sumiyoshi T, Moriguchi M, Kanemoto H, Asakura K, Sasaki K, Sugiura T, Mizuno T, Uesaka K. Liver-specific contrast agent-enhanced magnetic resonance and 18F-fluorodeoxyglucose positron emission tomography findings of hepatocellular adenoma: report of a case. Surg Today. 2012;42:200-204. [PMID: 22160355 DOI: 10.1007/s00595-011-0067-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
434 Aziz H, Brown ZJ, Eskander MF, Aquina CT, Baghdadi A, Kamel IR, Pawlik TM. A Scoping Review of the Classification, Diagnosis, and Management of Hepatic Adenomas. J Gastrointest Surg. [DOI: 10.1007/s11605-022-05246-8] [Reference Citation Analysis]
435 Voevoda MI, Ivanova AA, Shakhtshneider EV, Ovsyannikova AK, Mikhailova SV, Astrakova KS, Voevoda SM, Rymar OD. Molecular genetics of maturity-onset diabetes of the young. Ter arkh 2016;88:117. [DOI: 10.17116/terarkh2016884117-124] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
436 Sciarra A, Schmidt S, Pellegrinelli A, Maggioni M, Dondossola D, Pasquier J, Cigala C, Tosi D, Halkic N, Bulfamante G, Viale G, Bosari S, Balabaud C, Bioulac-Sage P, Sempoux C. OATPB1/B3 and MRP3 expression in hepatocellular adenoma predicts Gd-EOB-DTPA uptake and correlates with risk of malignancy.Liver Int. 2019;39:158-167. [PMID: 30218633 DOI: 10.1111/liv.13964] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
437 Pai RK, Wilcox R, Hart J. Molecular Gastrointestinal, Liver, and Pancreatic Pathology. Cell and Tissue Based Molecular Pathology. Elsevier; 2009. pp. 269-95. [DOI: 10.1016/b978-044306901-7.50028-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
438 Haddouche A, Bellanne-Chantelot C, Rod A, Fournier L, Chiche L, Gautier JF, Timsit J, Laboureau S, Chaillous L, Valero R, Larger E, Jeandidier N, Wilhelm JM, Popelier M, Guillausseau PJ, Thivolet C, Lecomte P, Benhamou PY, Reznik Y. Liver adenomatosis in patients with hepatocyte nuclear factor-1 alpha maturity onset diabetes of the young (HNF1A-MODY): Clinical, radiological and pathological characteristics in a French series. J Diabetes 2020;12:48-57. [PMID: 31166087 DOI: 10.1111/1753-0407.12959] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
439 Jin YJ, Lee JW, Park SW, Lee JI, Lee DH, Kim YS, Cho SG, Jeon YS, Lee KY, Ahn SI. Survival outcome of patients with spontaneously ruptured hepatocellular carcinoma treated surgically or by transarterial embolization. World J Gastroenterol 2013; 19(28): 4537-4544 [PMID: 23901230 DOI: 10.3748/wjg.v19.i28.4537] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
440 Arrivé L, Zucman-Rossi J, Balladur P, Wendum D. Hepatocellular adenoma with malignant transformation in a patient with neonatal portal vein thrombosis. Hepatology 2016;64:675-7. [PMID: 27042773 DOI: 10.1002/hep.28590] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
441 Ling C, Khalid S, Martin D, Hanson J, Castresana D, McCarthy D. HCCs and HCAs in Non-cirrhotic Patients: What You See May Not Be Enough. Dig Dis Sci 2019;64:3440-5. [PMID: 31673903 DOI: 10.1007/s10620-019-05920-z] [Reference Citation Analysis]
442 Liu D, Liu P, Cao L, Zhang Q, Chen Y. Screening the key genes of hepatocellular adenoma via microarray analysis of DNA expression and methylation profiles. Oncol Lett. 2017;14:3975-3980. [PMID: 28943905 DOI: 10.3892/ol.2017.6673] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
443 Ozaki K, Harada K, Yamamoto T, Aoyagi H, Kaizaki Y, Yoshikawa J. Unclassified hepatocellular adenoma in a middle-aged woman with glucose intolerance. Clin J Gastroenterol 2018;11:75-82. [PMID: 29116626 DOI: 10.1007/s12328-017-0788-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
444 Cazorla A, Félix S, Valmary-Degano S, Sailley N, Thévenot T, Heyd B, Bioulac-Sage P. Polycystic ovary syndrome as a rare association with inflammatory hepatocellular adenoma: a case report. Clin Res Hepatol Gastroenterol 2014;38:e107-10. [PMID: 24994518 DOI: 10.1016/j.clinre.2014.05.005] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
445 Nault JC, Calderaro J, Di Tommaso L, Balabaud C, Zafrani ES, Bioulac‐sage P, Roncalli M, Zucman‐rossi J. Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis. Hepatology 2014;60:1983-92. [DOI: 10.1002/hep.27372] [Cited by in Crossref: 178] [Cited by in F6Publishing: 173] [Article Influence: 22.3] [Reference Citation Analysis]
446 Guo Y, Li W, Cai W, Zhang Y, Fang Y, Hong G. Diagnostic Value of Gadoxetic Acid-Enhanced MR Imaging to Distinguish HCA and Its Subtype from FNH: A Systematic Review. Int J Med Sci 2017;14:668-74. [PMID: 28824299 DOI: 10.7150/ijms.17865] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
447 Van der Borght S, Libbrecht L, Katoonizadeh A, Aerts R, Nevens F, Verslype C, Roskams TA. Nuclear β-catenin staining and absence of steatosis are indicators of hepatocellular adenomas with an increased risk of malignancy. Histopathology 2007;51:855-6. [DOI: 10.1111/j.1365-2559.2007.02862.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
448 Margonis GA, Ejaz A, Spolverato G, Rastegar N, Anders R, Kamel IR, Pawlik TM. Benign solid tumors of the liver: management in the modern era. J Gastrointest Surg 2015;19:1157-68. [PMID: 25560181 DOI: 10.1007/s11605-014-2723-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
449 Calderaro J, Nault JC, Bioulac-Sage P, Laurent A, Blanc JF, Decaens T, Zucman-Rossi J. ALDH3A1 is overexpressed in a subset of hepatocellular carcinoma characterised by activation of the Wnt/ß-catenin pathway. Virchows Arch 2014;464:53-60. [PMID: 24276407 DOI: 10.1007/s00428-013-1515-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
450 Kim SR, Kondo F, Otono Y, Imoto S, Ando K, Hirakawa M, Fukuda K, Sasaki M, Kim SK, Komaki T, Tsuchida S, Kobayashi S, Matsuoka T, Kudo M. Serum amyloid A and C-reactive protein positive nodule in alcoholic liver cirrhosis, hard to make definite diagnosis. Hepatol Res 2014;44:584-90. [PMID: 23607539 DOI: 10.1111/hepr.12145] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
451 Sempoux C, Bisig B, Couchy G, Balabaud C, Zucman-Rossi J, Bioulac-Sage P. Malignant transformation of a β-catenin inflammatory adenoma due to an S45 β-catenin-activating mutation present 12 years before. Hum Pathol 2017;62:122-5. [PMID: 27984126 DOI: 10.1016/j.humpath.2016.10.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
452 Chen YY, Yeh MM. Non-alcoholic fatty liver disease: A review with clinical and pathological correlation. J Formos Med Assoc 2021;120:68-77. [PMID: 32654868 DOI: 10.1016/j.jfma.2020.07.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
453 Laurent-bellue A, Girma A, Le Stanc E. Problème diagnostique posé par une lésion hépatique hypermétabolique en TEP à la fluorocholine (18F) : à propos d’un cas. Médecine Nucléaire 2013;37:282-8. [DOI: 10.1016/j.mednuc.2013.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
454 Bastati-Huber N, Pötter-Lang S, Ba-Ssalamah A. [Focal nodular hyperplasia and hepatocellular adenoma]. Radiologe 2015;55:18-26. [PMID: 25575723 DOI: 10.1007/s00117-014-2704-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
455 Roux M, Pigneur F, Calderaro J, Baranes L, Chiaradia M, Tselikas L, Decaens T, Costentin C, Laurent A, Azoulay D, Mallat A, Zafrani ES, Rahmouni A, Luciani A. Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI. J Magn Reson Imaging 2015;42:1249-58. [PMID: 25851028 DOI: 10.1002/jmri.24897] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
456 Wang DQ, Fiske LM, Carreras CT, Weinstein DA. Natural history of hepatocellular adenoma formation in glycogen storage disease type I. J Pediatr. 2011;159:442-446. [PMID: 21481415 DOI: 10.1016/j.jpeds.2011.02.031] [Cited by in Crossref: 68] [Cited by in F6Publishing: 60] [Article Influence: 6.2] [Reference Citation Analysis]
457 Laurent-puig P, Zucman-rossi J. Genetics of hepatocellular tumors. Oncogene 2006;25:3778-86. [DOI: 10.1038/sj.onc.1209547] [Cited by in Crossref: 243] [Cited by in F6Publishing: 226] [Article Influence: 15.2] [Reference Citation Analysis]
458 Bayard Q, Caruso S, Couchy G, Rebouissou S, Bioulac Sage P, Balabaud C, Paradis V, Sturm N, de Muret A, Guettier C, Bonsang B, Copie C, Letouzé E, Calderaro J, Imbeaud S, Nault JC, Zucman-Rossi J. Recurrent chromosomal rearrangements of ROS1, FRK and IL6 activating JAK/STAT pathway in inflammatory hepatocellular adenomas. Gut 2020;69:1667-76. [PMID: 31907296 DOI: 10.1136/gutjnl-2019-319790] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
459 van Aalten SM, Witjes CD, de Man RA, Ijzermans JN, Terkivatan T. Can a decision-making model be justified in the management of hepatocellular adenoma? Liver Int. 2012;32:28-37. [PMID: 22098685 DOI: 10.1111/j.1478-3231.2011.02667.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
460 Larriba MJ, González-Sancho JM, Barbáchano A, Niell N, Ferrer-Mayorga G, Muñoz A. Vitamin D Is a Multilevel Repressor of Wnt/b-Catenin Signaling in Cancer Cells. Cancers (Basel) 2013;5:1242-60. [PMID: 24202444 DOI: 10.3390/cancers5041242] [Cited by in Crossref: 76] [Cited by in F6Publishing: 73] [Article Influence: 8.4] [Reference Citation Analysis]
461 Dokmak S, Paradis V, Vilgrain V, Sauvanet A, Farges O, Valla D, Bedossa P, Belghiti J. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology. 2009;137:1698-1705. [PMID: 19664629 DOI: 10.1053/j.gastro.2009.07.061] [Cited by in Crossref: 266] [Cited by in F6Publishing: 199] [Article Influence: 20.5] [Reference Citation Analysis]
462 Cheng L, Liu Y, Wang W, Merritt JL, Yeh M. Hepatocellular Adenoma in a Patient with Ornithine Transcarbamylase Deficiency. Case Reports Hepatol 2019;2019:2313791. [PMID: 31662921 DOI: 10.1155/2019/2313791] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
463 Gjorgjieva M, Oosterveer MH, Mithieux G, Rajas F. Mechanisms by Which Metabolic Reprogramming in GSD1 Liver Generates a Favorable Tumorigenic Environment. Journal of Inborn Errors of Metabolism and Screening 2016;4:232640981667942. [DOI: 10.1177/2326409816679429] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
464 Gupta S, Naini BV, Munoz R, Graham RP, Kipp BR, Torbenson MS, Mounajjed T. Hepatocellular Neoplasms Arising in Association With Androgen Use. Am J Surg Pathol 2016;40:454-61. [PMID: 26685086 DOI: 10.1097/PAS.0000000000000576] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
465 Larson BK, Guindi M. Applying criteria for hepatocellular neoplasm of uncertain malignant potential reclassifies more than half of hepatocellular adenomas. Ann Diagn Pathol 2021;55:151833. [PMID: 34597957 DOI: 10.1016/j.anndiagpath.2021.151833] [Reference Citation Analysis]
466 Cieply B, Zeng G, Proverbs-Singh T, Geller DA, Monga SP. Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene. Hepatology 2009;49:821-31. [PMID: 19101982 DOI: 10.1002/hep.22695] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
467 Kim GW, Lee DH, Jeon YH, Yoo J, Kim SY, Lee SW, Cho HY, Kwon SH. Glutamine Synthetase as a Therapeutic Target for Cancer Treatment. Int J Mol Sci 2021;22:1701. [PMID: 33567690 DOI: 10.3390/ijms22041701] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
468 Nault JC, Zucman-Rossi J. TERT promoter mutations in primary liver tumors. Clin Res Hepatol Gastroenterol. 2016;40:9-14. [PMID: 26336998 DOI: 10.1016/j.clinre.2015.07.006] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 7.9] [Reference Citation Analysis]
469 Kakar S, Grenert JP, Paradis V, Pote N, Jakate S, Ferrell LD. Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor. Mod Pathol. 2014;27:1499-1509. [PMID: 24743216 DOI: 10.1038/modpathol.2014.50] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
470 Baheti AD, Yeh MM, O'Malley R, Lalwani N. Malignant Transformation of Hepatic Adenoma in Glycogen Storage Disease Type-1a: Report of an Exceptional Case Diagnosed on Surveillance Imaging. J Clin Imaging Sci. 2015;5:47. [PMID: 26430540 DOI: 10.4103/2156-7514.163991] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
471 Tekath M, Klotz T, Montoriol P, Joubert-zakeyh J, Garcier J, Da Ines D. Fat-containing lesions of the liver : A pictorial essay. Diagnostic and Interventional Imaging 2015;96:201-11. [DOI: 10.1016/j.diii.2013.11.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
472 Pérez Rojas J, Guarín Corredor MJ, Artes Martinez MJ, Vera Sempere FJ, Brisa Estelles C, Huart Peris MC, Hernandez Giron S. [Immunophenotypic classification of 3 cases of hepatocellular adenoma. Differential diagnosis with focal nodular hyperplasia]. Gastroenterol Hepatol 2013;36:388-95. [PMID: 23664829 DOI: 10.1016/j.gastrohep.2013.02.013] [Reference Citation Analysis]
473 Nault JC, Paradis V, Cherqui D, Vilgrain V, Zucman-Rossi J. Molecular classification of hepatocellular adenoma in clinical practice. J Hepatol. 2017;67:1074-1083. [PMID: 28733222 DOI: 10.1016/j.jhep.2017.07.009] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 14.2] [Reference Citation Analysis]
474 Alkofer B, Lepennec V, Chiche L. Hepatocellular cancer in the non-cirrhotic liver. J Visc Surg. 2011;148:3-11. [PMID: 21306970 DOI: 10.1016/j.jviscsurg.2010.12.012] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
475 Kulik LM. Advancements in hepatocellular carcinoma: . Current Opinion in Gastroenterology 2007;23:268-74. [DOI: 10.1097/mog.0b013e3280ec5113] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
476 Herman P, Fonseca GM, Kruger JAP, Jeismann VB, Coelho FF. Guidelines for the Treatment of Hepatocellular Adenoma in the Era of Molecular Biology: An Experience-Based Surgeons’ Perspective. J Gastrointest Surg 2021;25:1494-502. [DOI: 10.1007/s11605-020-04724-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
477 Bioulac-sage P, Cubel G, Balabaud C. Pathological diagnosis of hepatocellular adenoma in clinical practice. Diagnostic Histopathology 2011;17:521-9. [DOI: 10.1016/j.mpdhp.2011.10.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
478 Yiu WH, Pan CJ, Mead PA, Starost MF, Mansfield BC, Chou JY. Normoglycemia alone is insufficient to prevent long-term complications of hepatocellular adenoma in glycogen storage disease type Ib mice. J Hepatol. 2009;51:909-917. [PMID: 19376605 DOI: 10.1016/j.jhep.2008.11.026] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
479 Fujita N, Nishie A, Asayama Y, Ishigami K, Ushijima Y, Kakihara D, Nakayama T, Morita K, Ishimatsu K, Honda H. Hyperintense Liver Masses at Hepatobiliary Phase Gadoxetic Acid–enhanced MRI: Imaging Appearances and Clinical Importance. RadioGraphics 2020;40:72-94. [DOI: 10.1148/rg.2020190037] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
480 Kishnani PS, Chuang TP, Bali D, Koeberl D, Austin S, Weinstein DA, Murphy E, Chen YT, Boyette K, Liu CH, Chen YT, Li LH. Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease. Hum Mol Genet. 2009;18:4781-4790. [PMID: 19762333 DOI: 10.1093/hmg/ddp441] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 3.7] [Reference Citation Analysis]
481 zhang Y, Zhang FK, Wang BE. Advances in the relationship between canonical Wnt pathway and liver. Shijie Huaren Xiaohua Zazhi 2008; 16(9): 975-981 [DOI: 10.11569/wcjd.v16.i9.975] [Cited by in F6Publishing: 1] [Reference Citation Analysis]